ºÀÃŹú¼Ê | NanoSynergy ÊÖÒÕÆ½Ì¨ Tue, 30 Sep 2025 06:45:34 +0000 zh-CN hourly 1 ÉÅʳGABAµÄÉñÃØÊµÁ¦£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³× /?p=40304 /?p=40304#comments Tue, 30 Sep 2025 06:06:00 +0000 http://www.jialanhai.com/?p=40304

ÉÅʳGABAµÄÉñÃØÊµÁ¦£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³×

2025-09-30 14:06

   GABA£¬£¬£¬£¬£¬£¬¼´¦Ã-°±»ù¶¡Ëᣬ£¬£¬£¬£¬£¬ÊÇÖÐÊàÉñ¾­ÏµÍ³ÖÐʩչҪº¦×÷ÓõÄÒÖÖÆÐÔÉñ¾­µÝÖÊ¡£¡£Ëüͨ¹ýÓëGABAAºÍGABABÁ½ÖÖÀàÐ͵ÄÊÜÌåÏ໥×÷Ó㬣¬£¬£¬£¬£¬×ÊÖúµ÷Àí´óÄԺͼ¹ËèÖеÄÉñ¾­»î¶¯£¬£¬£¬£¬£¬£¬È·±£Éñ¾­ÐźÅת´ïµÄƽºâ¡£¡£GABAµÄºÏ³ÉÒÀÀµÓڹȰ±ËáºÍάÉúËØB6£¬£¬£¬£¬£¬£¬¶øËüÔÚ´óÄÔÖÐµÄÆ½ºâ¹ØÓÚÔ¤·ÀºÍÖÎÁÆÄ³Ð©Éñ¾­ºÍ¾«Éñ¼²²¡ÖÁ¹ØÖ÷Òª¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬GABA²»µ«ÔÚÉñ¾­ÏµÍ³ÄÚ²¿Ê©Õ¹×÷Ó㬣¬£¬£¬£¬£¬»¹Ó볦µÀ΢ÉúÎïȺÓйØÁª£¬£¬£¬£¬£¬£¬ÕâЩ΢ÉúÎïȺÄܹ»±¬·¢GABA£¬£¬£¬£¬£¬£¬½ø¶ø¿ÉÄÜͨ¹ý³¦µÀ-ÄÔÖáÓ°ÏìÇéÐ÷ºÍÈÏÖª¹¦Ð§[1]¡£¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDkvNjI5YTFiMGY3MWIyNzEyYWRiNjE5OTVjOTAyMDdmZDUucG5n

չʾ³¦µÀ-´óÄÔÖṦЧ×÷ÓõÄÄâÒé»úÖÆµÄʾÒâͼ



 1¡¢ÉÅʳÖеÄGABA¶Ô˯ÃßµÄÓ°Ïì

   ÉÅʳÖеÄGABA¶Ô˯ÃßµÄDZÔÚÓ°ÏìÒÑÒýÆðÑо¿ÕßµÄÐËȤ£¬£¬£¬£¬£¬£¬ÓÉÓÚËü¿ÉÄÜͨ¹ýÔöǿ˯ÃßÖÊÁ¿ºÍ³ÖÐøÊ±¼äÀ´×ÊÖú¸ÄÉÆË¯Ãß¡£¡£Ñо¿Åú×¢£¬£¬£¬£¬£¬£¬ÉãÈ븻º¬GABAµÄ´óÃ׿ÉÒÔ¸ÄÉÆÖÐÄ껼Õߺ;ø¾­ºó¸¾Å®µÄ˯Ãß״̬£¬£¬£¬£¬£¬£¬ÌØÊâÊÇÔÚïÔ̭˯ÃßDZÔÚÆÚºÍÌá¸ß˯ÃßЧÂÊ·½Ãæ¡£¡£¶¯ÎïʵÑéÒ²Åú×¢£¬£¬£¬£¬£¬£¬GABAµÄÉãÈëÄܹ»ÔöÌíѪÇåÍʺڼ¤ËØË®Æ½£¬£¬£¬£¬£¬£¬ÕâÊÇÒ»ÖÖÖ÷ÒªµÄµ÷Àí˯Ãß-ÐѾõÖÜÆÚµÄ¼¤ËØ¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬GABAÔö²¹¼ÁÔÚһЩСÐÍÁÙ´²ÊÔÑéÖÐÏÔʾ³öïÔ̭˯ÃßDZÔÚÆÚµÄÇ÷ÊÆ£¬£¬£¬£¬£¬£¬Ö»¹Ü¶ÔËùÓÐ˯Ãß²ÎÊýµÄÒ»ÖÂÐÔÓ°ÏìÉÐδ»ñµÃ֤ʵ¡£¡£Ö»¹ÜЧ¹ûÒòÑо¿ºÍ²ÎÊý¶øÒ죬£¬£¬£¬£¬£¬µ«ÉÅʳGABA¶Ô˯Ãߵįð¾¢Ó°ÏìÊÇÏÔ¶øÒ×¼ûµÄ£¬£¬£¬£¬£¬£¬ÕâΪ½øÒ»²½Ñо¿ÌṩÁËÓÐÏ£ÍûµÄÆ«Ïò¡£¡£Î´À´µÄÑо¿ÐèÒª±ê×¼»¯ÒªÁìºÍ¸üÆÕ±éµÄÑùÔ­À´¸üºÃµØÃ÷È·GABA×÷Ϊ˯Ã߸¨ÖúµÄDZÁ¦¡£¡£

 2¡¢ÉÅʳÖÐGABA¶Ô½¹ÂǵÄÓ°Ïì


   ÉÅʳÖеÄGABA¶Ô½¹ÂǵÄÓ°ÏìÒѾ­»ñµÃÁËһЩÑо¿µÄÖ§³Ö¡£¡£ÔÚ¶¯ÎïÄ£×ÓÖУ¬£¬£¬£¬£¬£¬¿Ú·þGABAÄÜÏÔÖøïÔÌ­ÇéÐ÷Ó¦¼¤ÒýÆðµÄ½¹ÂÇÑùÐÐΪ£¬£¬£¬£¬£¬£¬Í¨¹ýÌá¸ß¿ª·ÅÔ°µØÊÔÑéÖеÄÖÐÐÄÇøÓòÍ£Áôʱ¼äÒÔ¼°Ôڸ߼ÜÊ®×ÖÃÔ¹¬ÊÔÑéÖÐÔöÌí¿ª·Å±ÛµÄÍ£Áôʱ¼äÀ´ÌåÏÖ¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬GABAµÄÉãÈ뻹ÓëѪ½¬ÖÐÒ»Ñõ»¯µª´úл²úÆ·µÄˮƽÏà¹Ø£¬£¬£¬£¬£¬£¬ÕâÅú×¢GABA¿ÉÄÜͨ¹ýÓ°ÏìÒ»Ñõ»¯µªµÄ´úлÀ´Ê©Õ¹Æä¿¹½¹ÂÇ×÷Óᣡ£

   ÔÚÈËÀàÑо¿ÖУ¬£¬£¬£¬£¬£¬GABAÇ¿»¯Ê³Î£¬£¬£¬£¬£¬ÈçÇÉ¿ËÁ¦£¬£¬£¬£¬£¬£¬Í¨¹ýÐÄÂʱäÒìÐÔºÍÍÙÒºÖеÄÊȸõÁ£ÂѰ×AˮƽÀ´ÆÀ¹ÀѹÁ¦£¬£¬£¬£¬£¬£¬ÏÔʾ³ö½µµÍÐÄÀíѹÁ¦µÄDZÁ¦¡£¡£ÕâЩÑо¿Ð§¹ûÅú×¢£¬£¬£¬£¬£¬£¬GABAÇ¿»¯Ê³Îï¿ÉÄÜͨ¹ýµ÷Àí×ÔÖ÷Éñ¾­ÏµÍ³»î¶¯ºÍÓ°ÏìÓëѹÁ¦Ïà¹ØµÄÉúÎï±ê¼ÇÎïÀ´ïÔÌ­½¹ÂǸС£¡£

    3¡¢ÉÅʳÖÐGABA¶ÔÌÛÍ´µ÷ÀíµÄÓ°Ïì


   ÉÅʳGABA¶ÔÌÛÍ´µ÷ÀíµÄDZÔÚÓ°ÏìÊÇÌÛÍ´ÖÎÀíÑо¿µÄÒ»¸öÐÂÐËÁìÓò¡£¡£GABA×÷ΪÖÐÊàÉñ¾­ÏµÍ³ÖеÄÒÖÖÆÐÔÉñ¾­µÝÖÊ£¬£¬£¬£¬£¬£¬Í¨¹ýµ÷ÀíÉñ¾­ÐË·ÜÐÔÔÚÌÛÍ´¸ÐÖªÖÐʩչҪº¦×÷Óᣡ£Ñо¿·¢Ã÷£¬£¬£¬£¬£¬£¬GABAˮƽµÄ½µµÍÓëÉñ¾­²¡ÀíÐÔÌÛÍ´Ä£×ÓÖÐÌÛÍ´Ãô¸Ð¶ÈµÄÔöÌíÓйØ£¬£¬£¬£¬£¬£¬ÕâÖÖ½µµÍ¿ÉÄÜÊÇÓÉÓÚGABAºÏ³ÉÊÜËð¡¢GABA±¬·¢Éñ¾­ÔªµÄËðʧ»òGABAתÔË»úÖÆµÄ¸Ä±ä¡£¡£

   ¿Ú·þGABAÔö²¹¼Á×÷ΪһÖÖ¿ÉÄܵÄÖÎÁÆÊֶΣ¬£¬£¬£¬£¬£¬ÒÑÏÔʾ³öͨ¹ýÔöÌí¼¹ËèGABA»îÐÔÀ´¼õÇáÌÛÍ´µÄDZÁ¦¡£¡£ÀýÈ磬£¬£¬£¬£¬£¬GABAÀàËÆÎïÒ©Î£¬£¬£¬£¬£¬Èç¼Ó°ÍÅç¶¡ºÍÆÕÈð°ÍÁÖ£¬£¬£¬£¬£¬£¬Í¨¹ýÓ°ÏìÌØ¶¨µÄÖÐÊàÉñ¾­ÏµÍ³Í¨µÀ£¬£¬£¬£¬£¬£¬ïÔÌ­Éñ¾­ÐË·Ü£¬£¬£¬£¬£¬£¬´Ó¶øÔÚÌÛÍ´ÖÎÁÆÖÐÏÔʾ³öЧ¹û¡£¡£

   4¡¢ÉÅʳGABA¾ßÓÐÉñ¾­±£»£»£»£»£»£»¤ºÍÈÏÖªÔöÇ¿×÷ÓÃ

   ÉÅʳGABAÏÔʾÈëÃÔ¾­±£»£»£»£»£»£»¤ºÍÈÏÖªÔöÇ¿µÄDZÁ¦£¬£¬£¬£¬£¬£¬ÕâÖ÷ÒªµÃÒæÓÚÆäÔÚµ÷ÀíÉñ¾­ÐźÅת´ïÖеÄÒÖÖÆ×÷Óᣡ£GABAÄܹ»Í¨¹ýÔö½øÒÖÖÆÐÔ×÷ÓúͼõÇáÉñ¾­ÔªµÄÌ«¹ýÐË·Ü£¬£¬£¬£¬£¬£¬À´ïÔÌ­Éñ¾­ËðÉ˺Íϸ°ûéæÃü£¬£¬£¬£¬£¬£¬´Ó¶ø·´¿¹ÐË·ÜÐÔ¶¾ÐÔ¡£¡£ÔÚ¶¯ÎïÄ£×ÓÖУ¬£¬£¬£¬£¬£¬¿Ú·þGABA»òGABAÔö²¹¼ÁÒѱ»Ö¤ÊµÄܹ»¸ÄÉÆÑ§Ï°ºÍÓ°ÏóÌåÏÖ£¬£¬£¬£¬£¬£¬ÒÔ¼°Ó°Ïì´óÄÔÖÐGABAºÍ¹È°±ËáµÄº¬Á¿¡£¡£

   ±ðµÄ£¬£¬£¬£¬£¬£¬GABAµÄÉãÈ뻹Óë¸ÄÉÆÈÏÖª¹¦Ð§Ïà¹Ø£¬£¬£¬£¬£¬£¬ÀýÈçÔÚÈËÀàÑо¿ÖУ¬£¬£¬£¬£¬£¬Ò»¶¨¼ÁÁ¿µÄGABAÉãÈë±»ÊӲ쵽¿ÉÒÔÌá¸ß×¢ÖØÁ¦Ñ¡ÔñºÍʱ¼ä×¢ÖØÁ¦Ê¹ÃüµÄÌåÏÖ¡£¡£GABAµÄÕâЩ×÷ÓÿÉÄܶÔÖÎÁÆ´´ÉËÐÔÄÔËðÉ˺ÍÉñ¾­ÍËÐÐÐÔ¼²²¡µÈ¾ßÓÐÖ÷ÒªÒâÒå¡£¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDkvYTlmNmNkM2RiNWM0MDhmMmFjZTA0YjgzZjYzM2U4YjUucG5n

Ð˷ܶ¾ÐÔ»úÖÆÓÕµ¼±í´ï GABA ºÍ¹È°±ËáÊÜÌåµÄϸ°û±¬·¢²¡Àíת±ä£¬£¬£¬£¬£¬£¬µ¼ÖÂϸ°ûéæÃü


   5¡¢³¦µÀ΢ÉúÎﱬ·¢µÄ GABA µÄ×÷ÓÃ

   ³¦µÀ΢ÉúÎïȺ±¬·¢µÄGABAÔÚµ÷ÀíÉñ¾­ÏµÍ³¹¦Ð§·½ÃæÊÎÑÝ×ÅÖ÷Òª½ÇÉ«¡£¡£Ìض¨µÄ³¦µÀϸ¾ú£¬£¬£¬£¬£¬£¬ÈçÈéËá¸Ë¾úºÍË«Æç¸Ë¾ú£¬£¬£¬£¬£¬£¬Äܹ»½«¹È°±Ëáת»¯ÎªGABA¡£¡£ÕâÖÖ΢ÉúÎïÔ´µÄGABAͨ¹ý³¦µÀ-ÄÔÖáÓ°ÏìÇéÐ÷ºÍÈÏÖª¹¦Ð§£¬£¬£¬£¬£¬£¬¿ÉÄܶÔÖÎÁƽ¹ÂÇ¡¢ÒÖÓôºÍÉñ¾­ÍËÐÐÐÔ¼²²¡¾ßÓÐDZÁ¦¡£¡£Ñо¿Åú×¢£¬£¬£¬£¬£¬£¬³¦µÀ΢ÉúÎïȺµÄʧµ÷Óë¶àÖÖÉñ¾­ÏµÍ³¼²²¡ÓйØ£¬£¬£¬£¬£¬£¬¶øÍ¨¹ýÒæÉú¾úºÍÒûʳ¸ÉÔ¤µ÷Àí³¦µÀ΢ÉúÎïȺ£¬£¬£¬£¬£¬£¬¿ÉÄÜÓÐÖúÓÚ»Ö¸´GABAˮƽ£¬£¬£¬£¬£¬£¬¸ÄÉÆÉñ¾­¿µ½¡¡£¡£

   6¡¢×ܽáºÍÕ¹Íû

   ÏÖÔÚ¶à·½ÃæµÄÑо¿ÉÅʳGABA¶ÔÉñ¾­ÏµÍ³£¬£¬£¬£¬£¬£¬°üÀ¨Æä¶Ô˯Ãß¡¢½¹ÂÇ¡¢ÌÛÍ´¡¢ÈÏÖªºÍѪѹµÄDZÔÚÒæ´¦¡£¡£Ñо¿Åú×¢£¬£¬£¬£¬£¬£¬GABAÄܹ»Í¨¹ýѪÄÔÆÁÕÏ£¬£¬£¬£¬£¬£¬Ó°ÏìÉñ¾­µÝÖÊµÄÆ½ºâ£¬£¬£¬£¬£¬£¬¿ÉÄÜÓÐÖúÓÚ¸ÄÉÆÉñ¾­ºÍ¾«Éñ¿µ½¡¡£¡£Ö»¹Ü¶¯ÎïÄ£×ÓºÍÆðÔ´ÈËÀàÑо¿ÌṩÁËÆð¾¢Ö¤¾Ý£¬£¬£¬£¬£¬£¬µ«ÈËÀàÊý¾ÝÓÐÏÞ£¬£¬£¬£¬£¬£¬ÐèÒª¸üÉîÈëµÄÑо¿À´È·¶¨GABAµÄ×î¼Ñ¼ÁÁ¿¡¢Åä·½ºÍºã¾ÃÓ°Ïì¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬GABAµÄ΢ÉúÎïȺ±¬·¢Í¾¾¶Ò²Í»ÏÔÁ˳¦µÀ-ÄÔÖáÔÚÉñ¾­µ÷ÀíÖеÄÖ÷Òª×÷Ó㬣¬£¬£¬£¬£¬ÎªÎ´À´µÄ¸öÐÔ»¯ÓªÑøºÍÖÎÁÆÕ½ÂÔÌṩÁËÐÂ˼Ð÷¡£¡£



²Î¿¼ÎÄÏ×

1. Almutairi S, Sivadas A, Kwakowsky A. The Effect of Oral GABA on the Nervous System: Potential for Therapeutic Intervention. Nutraceuticals. 2024;4(2):241-259. doi:10.3390/nutraceuticals4020015


·ÖÏíµ½£º

ÔĶÁ¸ü¶àÎÄÕÂ
READ MORE

]]> /?feed=rss2&p=40304 0 άÉúËØDÊÇά³ÖÈËÌ念½¡µÄÒªº¦Î¢Á¿ÓªÑøËØ /?p=40294 /?p=40294#comments Thu, 28 Aug 2025 06:45:44 +0000 http://www.jialanhai.com/?p=40294

ÉÅʳGABAµÄÉñÃØÊµÁ¦£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³×

2025-09-30 14:06

   

  άÉúËØD£¬£¬£¬£¬£¬£¬ÕâÖÖÖÁ¹ØÖ÷ÒªµÄ΢Á¿ÓªÑøËØ£¬£¬£¬£¬£¬£¬¶ÔºÀÃŹú¼Ê¹Ç÷À¿µ½¡ºÍ¶àÖÖÐÄÀíÀú³ÌÆðמöÒéÐÔ×÷Óᣡ£ÔÚÌåÄÚ£¬£¬£¬£¬£¬£¬Î¬ÉúËØDת»¯Îª25(OH)DºÍ1,25(OH)2D£¬£¬£¬£¬£¬£¬Óë¼××´ÅÔÏÙ¼¤ËØÐ­Í¬ÊÂÇ飬£¬£¬£¬£¬£¬ÒÔ׼ȷµ÷¿ØÑª¸ÆË®Æ½¡£¡£×îеÄÑо¿Ò»Ö±Õ¹ÏÖάÉúËØDÔÚÔ¤·ÀÐÄѪ¹Ü¼²²¡¡¢×ÔÉíÃâÒß¼²²¡¡¢Ñ¬È¾ÒÔ¼°Ä³Ð©ÀàÐͰ©Ö¢·½ÃæµÄÒªº¦×÷Óᣡ£2024Ä꣬£¬£¬£¬£¬£¬ÃÀ¹úÐÄÔà´úлºÍÄÚÉøÍ¸Ñо¿ËùµÄ×îÐÂÑо¿Ç¿µ÷£¬£¬£¬£¬£¬£¬ÎªÁËʵÏÖ¼²²¡Ô¤·ÀµÄ×î¼ÑЧ¹û£¬£¬£¬£¬£¬£¬½¨Ò齫25(OH)Dˮƽά³ÖÔÚ40ÖÁ80ng/mLµÄ¹æÄ£ÄÚ[1]¡£¡£

  άÉúËØDȱ·¦µÄ½ç˵άÉúËØDȱ·¦£ºÑªÇå25(OH)DŨ¶ÈµÍÓÚ40ng/mL£¬£¬£¬£¬£¬£¬ÎÞ·¨Öª×ãÆäÐÄÀíºÍÉúÎ﹦ЧµÄÐèÇ󡣡£ÑÏÖØÎ¬ÉúËØDȱ·¦£ºÑªÇå25(OH)DŨ¶ÈµÍÓÚ12ng/mL£¬£¬£¬£¬£¬£¬´Ëʱ¸öÌå¿ÉÄ᷺ܻÆðÓëάÉúËØDȱ·¦Ïà¹ØµÄÖ¢×´¡£¡£Î¬ÉúËØD¸»×㣺ѪÇå25(OH)DŨ¶È¸ßÓÚ50ng/mL£¬£¬£¬£¬£¬£¬ÕâÊÇά³ÖÕûÌ念½¡ºÍǿ׳ÐÄÀí¹¦Ð§Ëù±ØÐèµÄ¡£¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvZmMzZWQ1MTk2NGE0ZThkZDc5MTVlZWQ5MmE0YmM1YmUucG5n


1. Î¬ÉúËØDµÄÖ÷ÒªÐÔ¼°È«Çòȱ·¦ÏÖ×´


  άÉúËØDÊÇά³ÖÈËÌ念½¡µÄ±ØÐè΢Á¿ÓªÑøËØ£¬£¬£¬£¬£¬£¬¶Ô¹Ç÷À¿µ½¡ÓÈÆäÖ÷Òª¡£¡£ËüÔÚÌåÄÚת»¯Îª25(OH)DºÍ1,25(OH)2D£¬£¬£¬£¬£¬£¬Óë¼××´ÅÔÏÙ¼¤ËØÅäºÏµ÷ÀíѪ¸ÆË®Æ½£¬£¬£¬£¬£¬£¬Ó°ÏìÉñ¾­¼¡È⹦Ч¡£¡£Î¬ÉúËØD»¹¶ÔÔ¤·À¶àÖÖ¼²²¡ÓÐÆð¾¢×÷Ó㬣¬£¬£¬£¬£¬°üÀ¨ÐÄѪ¹Ü²¡¡¢´úл¼²²¡¡¢×ÔÉíÃâÒß¼²²¡¡¢Ñ¬È¾ºÍijЩ°©Ö¢¡£¡£Î¬ÉúËØDȱ·¦»á¼Ó¾çÑ×Ö¢ºÍ´úлÔÓÂÒ£¬£¬£¬£¬£¬£¬ÔöÌíѬȾ·çÏÕ¡£¡£Òò´Ë£¬£¬£¬£¬£¬£¬Î¬³ÖѪÇå25(OH)DˮƽÔÚ40ng/mLÒÔÉ϶Կµ½¡ÖÁ¹ØÖ÷Òª¡£¡£

  È«ÇòÁè¼Ý°ëÊýµÄÈËÒòȱ·¦ÈÕɹ¶øÎ¬ÉúËØDȱ·¦£¬£¬£¬£¬£¬£¬ÓÈÆäÔÚÔ¶Àë³àµÀµÄµØÇø¡£¡£Îª¸ÄÉÆÕâһ״̬£¬£¬£¬£¬£¬£¬ÐèÒªÌá¸ß¹«ÖÚ¶ÔÇå¾²ÈÕɹ¡¢ÒûʳȪԴºÍÔö²¹Î¬ÉúËØDµÄÊìϤ¡£¡£Ä¿½ñµÄάÉúËØDÉãÈ뽨Òéͨ³£Î´ÄÜÖª×ãÈËÌåÐèÇ󣬣¬£¬£¬£¬£¬ÓÉÓÚËüÃÇûÓÐ˼Á¿µ½Î¬ÉúËØDÔÚ¼²²¡Ô¤·À·½ÃæµÄ×÷Óᣡ£È«Çò¹æÄ£ÄÚ£¬£¬£¬£¬£¬£¬ÓÉÓÚÈÕɹȱ·¦ºÍ×èÖ¹Ñô¹âµÄÐÐΪ£¬£¬£¬£¬£¬£¬Î¬ÉúËØDȱ·¦ÆÕ±é±£´æ£¬£¬£¬£¬£¬£¬µ¼ÖÂÁè¼Ý°ëÊýµÄÉú³ÝѪÇå25(OH)DˮƽµÍÓÚ40ng/mL¡£¡£ÕâÖÖȱ·¦×´Ì¬¿ÉÄÜ»á¼Ó¾ç¶àÖÖ¼²²¡£¬£¬£¬£¬£¬£¬ÔöÌíÆäËû¼²²¡µÄÒ׸ÐÐÔ¡£¡£

  ΪÁ˸ÄÉÆÕâһ״̬£¬£¬£¬£¬£¬£¬ÐèÒªÌá¸ß¹«ÖÚ¶ÔάÉúËØDÖ÷ÒªÐÔµÄÊìϤ£¬£¬£¬£¬£¬£¬ÃãÀøÇå¾²µÄÈÕɹϰ¹ß£¬£¬£¬£¬£¬£¬ÔöÌíÒûʳÖÐάÉúËØDµÄÉãÈ룬£¬£¬£¬£¬£¬²¢ÔÚÐëҪʱÔö²¹¡£¡£Ö»¹ÜÓÐÖ¤¾ÝÅú×¢£¬£¬£¬£¬£¬£¬Î¬³Ö25(OH)DŨ¶ÈÔÚ40ÖÁ80ng/mL¹æÄ£ÄÚ¶Ô¿µ½¡ºÍ¼²²¡Ô¤·À×îΪÀíÏ룬£¬£¬£¬£¬£¬µ«Ðí¶àÕþ¸®ºÍ¿µ½¡»ú¹¹µÄÍÆ¼öÁ¿ÈÔȻƫµÍ£¬£¬£¬£¬£¬£¬Î´Äܳä·ÖʹÓÃάÉúËØDÔÚÔö½ø¿µ½¡·½ÃæµÄDZÁ¦¡£¡£Òò´Ë£¬£¬£¬£¬£¬£¬ÖØÐÂÆÀ¹ÀºÍ¸üÐÂάÉúËØDµÄÍÆ¼öÉãÈëÁ¿¹ØÓÚ¸ÄÉÆÈ«ÇòÉú³ÝµÄ¿µ½¡×´Ì¬ÖÁ¹ØÖ÷Òª¡£¡£Í¨¹ýÌá¸ßѪÇå25(OH)Dˮƽ£¬£¬£¬£¬£¬£¬²»µ«¿ÉÒÔÔöÇ¿¹Ç÷À¿µ½¡£¬£¬£¬£¬£¬£¬»¹¿ÉÒÔ½µµÍ¶àÖÖÂýÐÔ¼²²¡ºÍ¼±ÐÔѬȾµÄ·çÏÕ£¬£¬£¬£¬£¬£¬´Ó¶øÌá¸ßÉúÑÄÖÊÁ¿²¢ïÔÌ­Ò½ÁƱ£½¡±¾Ç®¡£¡£

2. Î¬ÉúËØDµÄºÏ³É


  άÉúËØDµÄºÏ³ÉÊÇά³ÖÈËÌ念½¡µÄÒªº¦Àú³Ì¡£¡£Ö»¹Ü¿ÉÒÔͨ¹ýʳÎïºÍÔö²¹¼ÁÉãȡάÉúËØD£¬£¬£¬£¬£¬£¬µ«´ó²¿·ÖάÉúËØDµÄȪԴÊÇͨ¹ýƤ·ô̻¶ÓÚÑô¹âÖеÄ×ÏÍâÏßB£¨UVB£©À´ºÏ³ÉµÄ¡£¡£Æ¤·ôÖеÄ7-ÍÑÇ⵨¹Ì´¼£¨7-DHC£©ÔÚUVBÕÕÉäÏÂת»¯ÎªÇ°Î¬ÉúËØD3£¬£¬£¬£¬£¬£¬½ø¶øÍ¨¹ýÈÈÒì¹¹»¯ÐγÉάÉúËØD3¡£¡£Õâ¸öÀú³ÌµÄЧÂÊÊܵ½¶àÖÖÒòËØµÄÓ°Ï죬£¬£¬£¬£¬£¬°üÀ¨Æ¤·ôÉ«ËØº¬Á¿¡¢UVBµÄÇ¿¶ÈºÍ³ÖÐøÊ±¼ä¡¢Ò»ÌìÖеÄʱ¼ä¡¢¼¾½Ú¡¢Ê¹ÓõķÀɹ²úÆ·»òÒÂÎïÒÔ¼°Æ¤·ô״̬µÈ¡£¡£


  άÉúËØD3ÔÚÌåÄÚ¾­ÓÉһϵÁдúлÀú³Ì£¬£¬£¬£¬£¬£¬×îÖÕת»¯ÎªÆä»îÐÔÐÎʽ¡ª¡ª¸Æ»¯Èý´¼£¨1,25(OH)2D£©¡£¡£Ê×ÏÈ£¬£¬£¬£¬£¬£¬Î¬ÉúËØD3ÔÚ¸ÎÔàÖо­ÓÉ25-ôÇ»¯Ã¸µÄ×÷ÓÃת»¯Îª25-ôÇ»ùάÉúËØD£¨25(OH)D£©£¬£¬£¬£¬£¬£¬ÕâÊÇάÉúËØD״̬µÄ×î¼ÑÉúÎï±ê¼ÇÎï¡£¡£Ëæºó£¬£¬£¬£¬£¬£¬25(OH)DÔÚÉöÔàÖеÄ1¦Á-ôÇ»¯Ã¸×÷ÓÃϽøÒ»²½×ª»¯Îª1,25(OH)2D£¬£¬£¬£¬£¬£¬Ò²³ÆÎª¸Æ»¯Èý´¼¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬Ä³Ð©ÍâÖÜϸ°û£¬£¬£¬£¬£¬£¬ÈçÃâÒßϸ°û£¬£¬£¬£¬£¬£¬Ò²ÄÜͨÏ꾡°ûÄÚµÄ1¦Á-ôÇ»¯Ã¸½«25(OH)Dת»¯Îª1,25(OH)2D£¬£¬£¬£¬£¬£¬Õâ¹ØÓÚËüÃǵı£»£»£»£»£»£»¤ÐÔÐÄÀí×÷ÓÃÖÁ¹ØÖ÷Òª¡£¡£


  ÖµµÃ×¢ÖØµÄÊÇ£¬£¬£¬£¬£¬£¬Æ¤·ôºÏ³ÉάÉúËØDµÄÄÜÁ¦¾ßÓÐÄÚÔڵķ´À¡»úÖÆ£¬£¬£¬£¬£¬£¬¿ÉÒÔ·ÀÖ¹Òò¹ý¹ý»îɹ¶øµ¼ÖÂѪҺÖÐάÉúËØD¹ýÁ¿£¬£¬£¬£¬£¬£¬´Ó¶ø×èֹάÉúËØDÖж¾»ò¸ß¸ÆÑªÖ¢¡£¡£È»¶ø£¬£¬£¬£¬£¬£¬ÕâÖֺϳÉÀú³ÌÔÚÔ糿ºÍ»Æ»è¡¢¶¬¼¾¡¢Í¨¹ýË«²ã²£Á§´°µÄÊÒÄÚÈÕɹ£¬£¬£¬£¬£¬£¬»òµ±Æ¤·ô±»ÒÂÎï»ò·Àɹ˪ÁýÕÖʱÏÕЩ²»»á±¬·¢¡£¡£Òò´Ë£¬£¬£¬£¬£¬£¬ÉúÑÄÔÚ¸ßγ¶ÈµØÇø»òÒòÎÄ»¯Ï°¹ß×èÖ¹ÈÕɹµÄÈËÃÇÍùÍùÃæÁÙάÉúËØDȱ·¦µÄ·çÏÕ£¬£¬£¬£¬£¬£¬Õâ¾ÍÐèҪͨ¹ýÒûʳ¡¢Ôö²¹¼Á»òÇå¾²µÄÈÕ¹âÔ¡À´È·±£×ã¹»µÄάÉúËØDˮƽ¡£¡£


3. Î¬ÉúËØDµÄÐÄÀí×÷ÓÃÓ뿵½¡Ö÷ÒªÐÔ


  άÉúËØDµÄÐÄÀíѧÊÇÒ»ÃÅÑо¿Î¬ÉúËØDÔÚÈËÌåÖÐ×÷ÓõĿÆÑ§¡£¡£ÕâÖÖÖ÷ÒªµÄÓªÑøËØÔÚÌåÄÚÊÎÑÝ×ŶàÖÖ½ÇÉ«£¬£¬£¬£¬£¬£¬ÆäÐÄÀí¹¦Ð§²»µ«ÏÞÓÚÖ§³Ö¹Ç÷À¿µ½¡£¬£¬£¬£¬£¬£¬»¹À©Õ¹µ½µ÷ÀíÃâÒßϵͳ¡¢Ó°Ïìϸ°ûÉú³¤ºÍ·Ö»¯£¬£¬£¬£¬£¬£¬ÒÔ¼°Î¬³ÖÕûÌ念½¡¡£¡£


  ¸Æ»¯Èý´¼£¬£¬£¬£¬£¬£¬ÊÇͨ¹ýһϵÁдúл·½·¨ÔÚÌåÄÚÌìÉúµÄ¡£¡£Õâ¸öÀú³Ì×îÏÈÓÚÆ¤·ô̻¶ÓÚ×ÏÍâÏßB£¨UVB£©Ï£¬£¬£¬£¬£¬£¬½«7-ÍÑÇ⵨¹Ì´¼£¨7-DHC£©×ª»¯ÎªÎ¬ÉúËØD3¡£¡£Ëæºó£¬£¬£¬£¬£¬£¬Î¬ÉúËØD3ÔÚ¸ÎÔàÖб»×ª»¯Îª25-ôÇ»ùάÉúËØD£¨25(OH)D£©£¬£¬£¬£¬£¬£¬²¢ÔÚÉöÔàÖнøÒ»²½×ª»¯Îª1,25(OH)2D¡£¡£ÖµµÃ×¢ÖØµÄÊÇ£¬£¬£¬£¬£¬£¬1,25(OH)2D²»µ«ÔÚÉöÔàÖб¬·¢£¬£¬£¬£¬£¬£¬Ä³Ð©ÍâÖÜϸ°û£¬£¬£¬£¬£¬£¬ÈçÃâÒßϸ°ûºÍÉÏÆ¤Ï¸°û£¬£¬£¬£¬£¬£¬Ò²ÄÜÆ¾Ö¤¾Ö²¿ÐèÒªºÏ³ÉÕâÖÖ¼¤ËØ¡£¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvMTExOTI3OTY5N2FlMzdiYmFkYTIyOGQ0MjNiNDg1MzkucG5n
7-ÍÑÇ⵨¹Ì´¼(7-DHC)ÔÚ̻¶ÓÚUVBÉäÏߺóÌìÉúάÉúËØD3µÄ;¾¶


  άÉúËØDÔÚµ÷Àí¸ÆºÍÁ×´úлÖÐÆð×ÅÖÁ¹ØÖ÷ÒªµÄ×÷Óᣡ£Ëüͨ¹ýÔö½ø³¦µÀ¶Ô¸ÆºÍÁ×µÄÎüÊÕ¡¢µ÷ÀíÉöÔà¶ÔÕâЩ¿óÎïÖʵÄÖØÎüÊÕ£¬£¬£¬£¬£¬£¬ÒÔ¼°Î¬³Ö¹Ç÷À¿ó»¯£¬£¬£¬£¬£¬£¬À´¼á³ÖѪҺÖиƺÍÁ×µÄŨ¶ÈÎȹÌ¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬Î¬ÉúËØD»¹¼ÓÈëµ÷Àí¼××´ÅÔÏÙ¼¤ËØ£¨PTH£©µÄÉøÍ¸£¬£¬£¬£¬£¬£¬ÕâÊÇÒ»ÖÖµ÷ÀíѪ¸ÆË®Æ½µÄÒªº¦¼¤ËØ¡£¡£


  ³ýÁËÕâЩ¾­µä¹¦Ð§Í⣬£¬£¬£¬£¬£¬Î¬ÉúËØD»¹¾ßÓÐÆÕ±éµÄ·Ç¹Ç÷ÀЧӦ¡£¡£ÀýÈ磬£¬£¬£¬£¬£¬Ëüͨ¹ýÓëάÉúËØDÊÜÌ壨VDR£©Á¬Ïµ£¬£¬£¬£¬£¬£¬Ó°Ïì»ùÒò±í´ï£¬£¬£¬£¬£¬£¬´Ó¶øµ÷ÀíÃâÒßϸ°ûµÄ¹¦Ð§¡£¡£ÕâÖÖµ÷Àí×÷ÓÃÓÐÖúÓÚÔ¤·ÀijЩ×ÔÉíÃâÒß¼²²¡ºÍijЩÀàÐ͵ݩ֢¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬Î¬ÉúËØD»¹¼ÓÈëµ÷Àíϸ°ûÔöÖ³¡¢·Ö»¯ºÍµòÍö£¬£¬£¬£¬£¬£¬Ó°Ï켡È⹦Ч£¬£¬£¬£¬£¬£¬ÉõÖÁÓ°ÏìÐÄÀí¿µ½¡£¬£¬£¬£¬£¬£¬°üÀ¨ÇéÐ÷ºÍÈÏÖª¹¦Ð§¡£¡£


  άÉúËØDµÄÐÄÀí×÷ÓÃÇ¿µ÷ÁËά³ÖÊʵ±ÑªÇå25(OH)DˮƽµÄÖ÷ÒªÐÔ¡£¡£Ñо¿Åú×¢£¬£¬£¬£¬£¬£¬µÍÓÚ40ng/mLµÄˮƽÓë¶àÖÖ¿µ½¡ÎÊÌâÏà¹Ø£¬£¬£¬£¬£¬£¬¶ø½«25(OH)DŨ¶Èά³ÖÔÚ40ÖÁ80ng/mL¹æÄ£ÄÚ¿ÉÄÜÓÐÖúÓÚÔ¤·À¶àÖÖÂýÐÔ¼²²¡¡£¡£Òò´Ë£¬£¬£¬£¬£¬£¬È·±£×ã¹»µÄάÉúËØDÉãÈë¹ØÓÚά»¤ÕûÌ念½¡ÖÁ¹ØÖ÷Òª¡£¡£


  È»¶ø£¬£¬£¬£¬£¬£¬ÓÉÓÚµØÀíλÖᢼ¾½Ú¡¢Æ¤·ôÉ«ËØ¡¢·ÀɹÐÐΪµÈÒòËØ£¬£¬£¬£¬£¬£¬Ðí¶àÈË¿ÉÄÜÎÞ·¨Í¨¹ýÈÕɹ»ñµÃ×ã¹»µÄάÉúËØD¡£¡£Òò´Ë£¬£¬£¬£¬£¬£¬ÒûʳºÍÔö²¹¼Á³ÉΪÖ÷ÒªµÄάÉúËØDȪԴ¡£¡£Ê³ÎïȪԴ°üÀ¨ÓÍÐÔÓãÀࡢǿ»¯Ê³ÎïºÍijЩ̹½£¬£¬£¬£¬£¬£¬µ«ÕâЩȪԴ¿ÉÄÜÎÞ·¨Ìṩ×ã¹»µÄάÉúËØD£¬£¬£¬£¬£¬£¬ÌØÊâÊǹØÓÚÓÐÌØ¶¨ÐèÇóµÄÈËȺ£¬£¬£¬£¬£¬£¬ÈçÍíÄêÈË¡¢Ôи¾ºÍµØÀíλÖÃÔ¶Àë³àµÀµÄÈËȺ¡£¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvNGNiZWUyNWZjMDI3YzQyMDNmMTJiMGFjMWNkZDU5YmUucG5n
άÉúËØ D£¨1,25(OH) 2 D£©µÄ¸üÆÕ±é¹¦Ð§£º¸Ãͼ˵Ã÷ÎúÓ°ÏìÉíÌåÖÖÖÖϸ°ûºÍ×éÖ¯µÄÄÚÉøÍ¸ºÍ·ÇÄÚÉøÍ¸¹¦Ð§

1. Î¬³ÖÐÄÀíѪÇå25(OH)DŨ¶ÈµÄ±¾Ç®


  άÉúËØDµÄ¿µ½¡¾­¼Ãѧǿµ÷ÁËά³ÖÊʵ±ÑªÇå25(OH)DŨ¶ÈµÄ±¾Ç®Ð§Òæ¡£¡£Î¬ÉúËØD×÷ΪһÖÖÆÕ±é¿ÉÓõÄ΢Á¿ÓªÑøËØ£¬£¬£¬£¬£¬£¬ÆäÔö²¹³ÉÄÚÇé¶Ô½ÏµÍ£¬£¬£¬£¬£¬£¬ÓÈÆäÓëÖÎÁÆÎ¬ÉúËØDȱ·¦Ïà¹Ø¼²²¡£¡£¨ÈçÐÄѪ¹Ü¼²²¡¡¢×ÔÉíÃâÒß¼²²¡¡¢Ä³Ð©°©Ö¢£©µÄ¸ß°ºÒ½ÁÆÓöÈÏà±È¡£¡£ÀýÈ磬£¬£¬£¬£¬£¬Î¬ÉúËØD3Ôö²¹¼ÁÔÚÎ÷·½Êг¡ÉϵÄÄ깩Ӧ±¾Ç®Í¨³£²»µ½8ÃÀÔª£¬£¬£¬£¬£¬£¬¶øÕë¶ÔάÉúËØDȱ·¦Ö¢µÄÖÎÁƺÍÏà¹Ø²¢·¢Ö¢µÄ´¦ÀíÓöȿÉÄÜÿÄê¸ß´ïÊýǧÖÁÊýÍòÃÀÔª¡£¡£

  ͨ¹ý¿Ú·þάÉúËØDÔö²¹¼Á»òͨ¹ýÇå¾²µÄÈÕɹÀ´Î¬³ÖѪÇå25(OH)DˮƽÔÚ40ÖÁ80ng/mLµÄ¹æÄ£ÄÚ£¬£¬£¬£¬£¬£¬¿ÉÒÔÏÔÖø½µµÍijЩÂýÐÔ¼²²¡µÄ·¢²¡ÂʺÍéæÃüÂÊ£¬£¬£¬£¬£¬£¬´Ó¶øïÔÌ­ºã¾ÃÒ½ÁÆÓöÈ¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬Í¨¹ýÔ¤·À¼²²¡£¬£¬£¬£¬£¬£¬Î¬ÉúËØDÔö²¹»¹¿ÉÄÜÌá¸ß¸öÌåµÄÉúÑÄÖÊÁ¿ºÍÊÂÇéÉú²úÁ¦¡£¡£

  ¹«¹²ÎÀÉúÕ½ÂÔ£¬£¬£¬£¬£¬£¬ÈçÃãÀøÑô¹âÕÕÉ䡢ʳÎïÇ¿»¯ºÍάÉúËØDÔö²¹Ö¸µ¼£¬£¬£¬£¬£¬£¬¿ÉÒÔ×÷Ϊ±¾Ç®Ð§Òæ¸ßµÄÊÖ¶ÎÀ´Ìá¸ßÈËȺµÄάÉúËØDˮƽ¡£¡£ÕâЩսÂÔµÄʵÑ鱾ǮԶµÍÓÚÖÎÁÆÎ¬ÉúËØDȱ·¦ÒýÆðµÄ¿µ½¡ÎÊÌâµÄÆÆ·Ñ¡£¡£Òò´Ë£¬£¬£¬£¬£¬£¬Í¶×ÊÓÚÔ¤·À²½·¥²»µ«ÓÐÖúÓÚÌá¸ß¹«¹²¿µ½¡Ë®Æ½£¬£¬£¬£¬£¬£¬»¹¿ÉÄÜÔÚ¾­¼ÃÉÏ´øÀ´½ÚÔ¼¡£¡£

2. ×ܽáÓëÕ¹Íû


  άÉúËØD×÷ΪҪº¦µÄ΢Á¿ÓªÑøËØ£¬£¬£¬£¬£¬£¬¶Ôά»¤¹Ç÷À¿µ½¡¡¢ÃâÒßϵͳµ÷ÀíÒÔ¼°Ô¤·À¶àÖÖÂýÐÔ¼²²¡ÖÁ¹ØÖ÷Òª¡£¡£Ä¿½ñÈ«ÇòÆÕ±é±£´æÎ¬ÉúËØDȱ·¦ÎÊÌ⣬£¬£¬£¬£¬£¬ÓÈÆäÊÇÔÚ¸ßγ¶ÈµØÇøºÍ×èÖ¹ÈÕɹµÄÈËȺÖС£¡£Î¬³Ö25(OH)DˮƽÔÚ40ÖÁ80ng/mL¹æÄ£ÄÚ£¬£¬£¬£¬£¬£¬²»µ«Äܹ»ÔöÇ¿¹Ç÷À¿µ½¡£¬£¬£¬£¬£¬£¬»¹ÄܽµµÍÂýÐÔ¼²²¡·çÏÕ£¬£¬£¬£¬£¬£¬Ìá¸ßÉúÑÄÖÊÁ¿¡£¡£

  δÀ´£¬£¬£¬£¬£¬£¬Í¨¹ýÌá¸ß¹«ÖÚ¶ÔάÉúËØDÖ÷ÒªÐÔµÄÊìϤ£¬£¬£¬£¬£¬£¬ÃãÀøÇå¾²ÈÕɹ¡¢ÔöÌíÒûʳÉãÈëºÍÊʵ±Ôö²¹£¬£¬£¬£¬£¬£¬ÓÐÍû¸ÄÉÆÈ«ÇòÉú³ÝµÄάÉúËØD״̬£¬£¬£¬£¬£¬£¬ïÔÌ­Ïà¹Ø¼²²¡µÄÒ½ÁƼ縺£¬£¬£¬£¬£¬£¬ÊµÏÖ¸üÆÕ±éµÄ¿µ½¡ºÍ¾­¼ÃÐ§Òæ¡£¡£

  ²Î¿¼ÎÄÏ×
1.Wimalawansa SJ. Physiology of Vitamin D-Focusing on Disease Prevention. Nutrients. 2024;16(11). doi:10.3390/nu16111666

·ÖÏíµ½£º

ÔĶÁ¸ü¶àÎÄÕÂ
READ MORE

]]>
/?feed=rss2&p=40304 0
ºÀÃŹú¼ÊЯÊÖÊ¥·å»Û ¿ªÆôÈ«ÐÂÔ˶¯ÓªÑøµÝËÍ·½Ê½ /?p=40285 /?p=40285#comments Mon, 11 Aug 2025 06:51:32 +0000 http://www.jialanhai.com/?p=40285

ÉÅʳGABAµÄÉñÃØÊµÁ¦£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³×

2025-09-30 14:06


7ÔÂ30ÈÕÉÏÎ磬£¬£¬£¬£¬£¬ºÀÃŹú¼ÊÊ×´´ÈËËÎåªöª¡¢ÁªºÏÊ×´´ÈËËïÈʺÆÒ»Ðе½·Ãº¼ÖÝÊ¥·å»ÛÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾£¬£¬£¬£¬£¬£¬»ñÊ¥·å»ÛÁªºÏÊ×´´ÈË¡¢Á½½ì°ÂÔËÌøÂí¹Ú¾üÂ¥ÔÆ¼°Õã½­Ê¡¹ãÎ÷É̻ᴴ»á»á³¤ÑîÒãµÄÈÈÇé½Ó´ý¡£¡£Ë«·½ÉîÈë̽ÌÖÔ˶¯´ó¿µ½¡ÁìÓòµÄÊÖÒÕÁ¢ÒìÓ빤ҵÈںϣ¬£¬£¬£¬£¬£¬¸æ¿¢Ô˶¯ÄÜÁ¿ÄÉÃ×ÅçÎíÏîÄ¿µÄÏàÖú¹²Ê¶£¬£¬£¬£¬£¬£¬ÎªÐÐÒµÊÖÒÕÉý¼¶Óë²úÆ·Ë¢ÐÂ×¢ÈëÇ¿¾¢¶¯ÄÜ¡£¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvOTNiODZlNWNiYzJiOTUwMWE0OWU2ZmJhNGUzZjU3NzQuanBn
¿ªÆôÓªÑøÔö²¹ÐÂʱ´ú

ºÀÃŹú¼ÊÊÇÈ«ÇòÄÉÃ×ÊÖÒÕÓ¦ÓÃÁìÓòµÄÁì¾üÆóÒµ£¬£¬£¬£¬£¬£¬ÓµÓÐÃÀ¹úרÀûÉ̱ê¾ÖÊÚȨµÄÊ×Ïî¿ÉÓÃÓÚÈËÌåµÄÄÉÃ×ÊÖÒÕרÀû¡£¡£¹«Ë¾´î½¨µÄÈ«ÐÂÄÉÃ×ÓªÑøËØµÝËÍÆ½Ì¨£¬£¬£¬£¬£¬£¬½â¾öÁ˹Űå¼ÁÐÍÎüÊÕºÍÍÌÑÊ·½ÃæµÄÀ§ÈÅ£¬£¬£¬£¬£¬£¬¾ßÓгä·ÖÎüÊÕ¡¢Çå¾²Îȹ̡¢Ê¹Óñã½ÝµÈÖî¶àÓÅÊÆ£¬£¬£¬£¬£¬£¬ÓÐÓõØÌáÉýÁËÓªÑøËØµÄÎüÊÕЧÂÊÓëÉúÎïʹÓöÈ¡£¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvYzA2YmYwYTFhMGJjNzMxOGM0YjhjZDRmZGQ2MzU5MjAuanBn
ÄÉÃ×ÊÖÒÕ¸³ÄÜÔ˶¯¿µ½¡

º¼ÖÝÊ¥·å»ÛÒÔ¡°¿Æ¼¼¸³ÄÜÔ˶¯¿µ½¡¡±Îª½¹µã¶¨Î»£¬£¬£¬£¬£¬£¬ÔÚÊ×´´ÈËÍŶÓÒýÁìÏÂÕ¹ÏÖÆæÒìÐÐÒµÓÅÊÆ¡£¡£´Ë´Î¿¼²ìÖ¼ÔÚ´î½¨Ç°ÑØÊÖÒÕÓëÔ˶¯¿µ½¡ÐèÇóµÄ¶Ô½ÓÇÅÁº¡£¡£½«´ó·Ö×ÓµÄÓªÑøÎïÖÊÖÆ±¸³ÉÄÉÃ×¼¶Ð¡·Ö×ÓÒºÌ壬£¬£¬£¬£¬£¬Í¨¹ý¶¨Á¿µÄ¹ã½ÇÅçÎí×°Ö㬣¬£¬£¬£¬£¬¾­¿ÚÇ»ð¤Ä¤ÎüÊÕÖ±½Ó½øÈëÈËÌåÑ­»·£¬£¬£¬£¬£¬£¬ÎªÔ˶¯³¡¾°¼´Ê±ÓªÑøÔö²¹Ìṩ¸ïÃüÐÔ¿ÉÄÜ¡£¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvYjA4ODVjY2EwNTJmMWI2MGU0ZGQ5NzNiNGRhZjY4MjEuanBn
ǿǿÁªÊÖ ¹²ÖþÔ˶¯´ó¿µ½¡ÐÂÉú̬

º¼ÖÝÊ¥·å»ÛµÄÊг¡µ÷ÑÐÏÔʾ£¬£¬£¬£¬£¬£¬80%µÄÔ˶¯Ï²»¶ÕßÒÔΪ¡°Ô˶¯Öеļ´Ê±ÓªÑøÔö²¹·½Ê½Î´±ã¡±£¬£¬£¬£¬£¬£¬65%µÄרҵÔË·¢¶¯µ£ÐÄ¡°½ºÄÒ¡¢Æ¬¼ÁµÈ¹Å°åÔö²¹¼ÁÓг¦Î¸´úл¼ç¸º¡±¡£¡£ºÀÃŹú¼ÊÄÉÃ×ÊÖÒÕ½«È«ÐÂÓªÑøËØµÝËÍ·½Ê½´Ó¡°ÊµÑéÊÒ¡±ÍÆÏò¡°Èü³¡¡±£¬£¬£¬£¬£¬£¬Ö÷´ò¡°30ÃëÆðЧ¡¢ÎÞ³¦Î¸¼ç¸º¡±£¬£¬£¬£¬£¬£¬Ìî²¹º£ÄÚÔ˶¯ÓªÑøËØÅçÎíµÄÊг¡¿Õȱ¡£¡£

¾ÝϤ£¬£¬£¬£¬£¬£¬Ë«·½ÍýÏëÈý¸öÔÂÄÚÍê³ÉÊ×Åú²úÆ·Åä·½µ÷ÊÔÓëСÊÔÉú²ú£¬£¬£¬£¬£¬£¬Ô¤¼ÆÄêµ×ÍÆ³öÊ׿îÁªÃû²úÆ·¡ª¡ªÔ˶¯ÄÜÁ¿ÄÉÃ×ÅçÎí¡£¡£´Ë´ÎÏàÖúÉî¶ÈÈÚºÏÁËÄÉÃ×ÊÖÒÕÓëÓªÑø¼´Ê±Ôö²¹³¡¾°£¬£¬£¬£¬£¬£¬¿ª´´ÐÐҵбê¸Ë£¬£¬£¬£¬£¬£¬Îª¹«¹²¿ÆÑ§Ô˶¯¡¢¸ßÐ§ÓªÑøÔö²¹Ìṩǿʢ¿Æ¼¼Ö§³Ö¡£¡£


·ÖÏíµ½£º

ÔĶÁ¸ü¶àÎÄÕÂ
READ MORE

]]>
/?feed=rss2&p=40304 0
Äϲý´óѧÑо¿·¢Ã÷£ºÈé¼Á¿ÉÄÜÓÐÖúÓÚÌá¸ßÓªÑøËØÎüÊÕÖúÁ¦¿µ½¡ /?p=40230 /?p=40230#comments Thu, 31 Jul 2025 03:56:00 +0000 http://www.jialanhai.com/?p=40230

Äϲý´óѧÑо¿·¢Ã÷£ºÈé¼Á¿ÉÄÜÓÐÖúÓÚÌá¸ßÓªÑøËØÎüÊÕÖúÁ¦¿µ½¡


  ¿ËÈÕ£¬£¬£¬£¬£¬£¬Äϲý´óѧÐû²¼ÁËһƪеÄÓªÑø±£½¡Æ·Èé¼ÁÉúÎïʹÓöȵÄÑо¿Ï£Íû£¬£¬£¬£¬£¬£¬¸ÃÑо¿ÉîÈë̽ÌÖÁËÓªÑøËØÈé¼ÁÔÚ¿Ú·þºóÔÚ賦µÀµÄת»¯Àú³Ì[1]¡£¡£Õ¹ÏÖÁËÈé¼ÁÔÚ¿Ú·þºóÔÚ賦µÀµÄ´¦ÀíÀú³Ì¶ÔÓªÑøÎïÖÊÉúÎïʹÓöȵÄÒªº¦Ó°Ï죬£¬£¬£¬£¬£¬Ç¿µ÷ÁËÓÅ»¯Èé¼ÁÎïÀí»¯Ñ§ÐÔ×ÓºÍÈ·±£ÆäÇå¾²ÐÔµÄÖ÷ÒªÐÔ¡£¡£


1.¿Ú·þÓªÑøÈéÒºµÄÏû»¯Àú³Ì

  µ±ÒºÌ¬O/WÈé¼Á½øÈë¿Úǻʱ£¬£¬£¬£¬£¬£¬ËüÃÇÓëÍÙÒº»ìÏý£¬£¬£¬£¬£¬£¬×îÏÈÆðÔ´µÄÏû»¯Àú³Ì¡£¡£ÍÙÒºÖеÄα-µí·Ûø×îÏȾÙÐеí·ÛµÄË®½â×÷Ó㬣¬£¬£¬£¬£¬½«Ê³ÎïÖеĿÉÏû»¯µí·Û²¿·Öת»¯ÎªÌÇ¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬¿ÚÇ»ð¤Ä¤Ò²¿ÉÄÜÊÇijЩÉúÎï»îÐÔ·Ö×Ó£¨ÈçάÉúËØB12¡¢½ª»ÆËغͰ×޼«´¼£©µÄÎüÊÕ²¿Î»¡£¡£ÔÚ¿ÚÇ»ÖУ¬£¬£¬£¬£¬£¬Èé¼Á¿ÉÄÜ»áÂÄÀúһϵÁеÄÎïÀíת±ä£¬£¬£¬£¬£¬£¬ÈçÒºµÎµÄÄý¾ÛºÍºÏ²¢¡£¡£ÕâЩ¸Ð¹ÙÌåÑ鹨ÓÚʳÎïºÍÒûÁϲúÆ·µÄ¿Ú¸ÐºÍ½ÓÊܶÈÖÁ¹ØÖ÷Òª¡£¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDcvNzRhZmU1Y2IwNGRjNjA4YTQ3NThjZWQzZjk1MTM1OTcucG5n

Èé¼ÁÔÚ賦µÀÏû»¯Àú³ÌÖпÉÄܱ¬·¢µÄÎïÀí»¯Ñ§ºÍÉúÎﻯѧת±äʾÒâͼ[2]


2.ÓªÑøËØÈé¼ÁÔÚθ²¿Ïû»¯Àú³Ì

  Èé¼ÁÔÚ¾­ÓÉ¿ÚÇ»ºó£¬£¬£¬£¬£¬£¬½øÈëθ²¿×îÏÈÊܵ½Î¸µÄÏû»¯ÇéÐεÄÓ°Ïì¡£¡£Î¸ÎªÒ»¸öËáÐÔÇéÐΣ¬£¬£¬£¬£¬£¬ÆäÖеÄθËáºÍÏû»¯Ã¸»áÓëÈé¼ÁÖеÄÒòËØ»¥¶¯¡£¡£ÕâÖÖ»¥¶¯¿ÉÄܵ¼ÖÂÈé¼ÁÖеÄÒºµÎ±¬·¢Äý¾Û¡¢ºÏ²¢»òÆäËûÎïÀíת±ä¡£¡£Î¸ÖеÄÏû»¯Ã¸£¬£¬£¬£¬£¬£¬ÈçθÂѰ×ø£¬£¬£¬£¬£¬£¬»á×îÏÈÆÊÎöÈé¼ÁÖеÄÂѰ×ÖÊ¡¢Ö¬·¾ºÍÆäËû´ó·Ö×Ó¡£¡£ÕâÒ»Àú³Ì¾öÒéÁËÓªÑøËØµÄÊÍ·ÅËÙÂʺͷ½Ê½¡£¡£


3.ÓªÑøËØÈé¼ÁÔÚС³¦Ïû»¯Àú³Ì

  ÈËÀàµÄС³¦º¬ÓÐÄܹ»Ïû»¯Èé¼ÁÖÐÖÖÖÖ´ó·Ö×ÓµÄÖØ´óø»ìÏýÎï¡£¡£Ð¡³¦Òº°üÀ¨µ¨ÑΣ¨Ò»ÖÖÉúÎïÍâò»îÐÔ¼Á£©¡¢µç½âÖʺͶàÖÖÏû»¯Ã¸£¬£¬£¬£¬£¬£¬ÒÔÔö½øÏû»¯ºÍÎüÊÕÀú³Ì¡£¡£ÒÈÏٵĵí·Ûø¡¢ÂѰ×øºÍÖ¬·¾Ã¸»áË®½âÈé¼ÁÖб£´æµÄÖÖÖÖµí·Û¡¢ÂѰ×ÖʺÍÖ¬·¾¡£¡£ÕâЩ×é·Ö¿ÉÄÜÊÇÈé¼ÁÖеÄ£¬£¬£¬£¬£¬£¬Ò²¿ÉÄÜÊÇÓÉʳÎïÖÐÆäËûÒòËØÐγɵÄ¡£¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDcvYjFkNzVkMDI0MjViNjg0ZDc2MDU5ODc4MDdlNWEwNWUucG5n

Ë®°üÓÍÈé¼ÁÔÚС³¦Ïû»¯Àú³ÌÖиÄÉÆÇ×Ö¬ÐÔÓªÑø±£½¡Æ·ÉúÎï¿É¼°ÐÔµÄDZÔÚ»úÖÆ


4.ÓªÑøËØµÄ½ºÊø»¯

  ½ºÊø»¯ÊÇÒ»¸öÉæ¼°»ìÏý½ºÊø£¨°üÀ¨½ºÊøºÍÄÒÅÝ£©ÐγɵÄÀú³Ì£¬£¬£¬£¬£¬£¬ËüÓÐÖúÓÚÖ¬½â²úÆ·ºÍÆäËûÇ×Ö¬·Ö×Ó£¬£¬£¬£¬£¬£¬ÈçÇ×Ö¬ÓªÑøËØµÄÁ¬Ïµ¡£¡£ÕâÖÖÁ¬ÏµÄÜÁ¦ºÜºéÁ÷ƽÉÏÈ¡¾öÓÚ»ìÏý½ºÊøÄÚ²¿ÐγɵÄÊèË®ÇøÓòµÄ¾Þϸ£¬£¬£¬£¬£¬£¬¶øÕâ¸ö¾ÞϸÓÖÓëÓÍÏàÖÐÖ¬·¾ËáµÄÁ´³¤ÓйØ¡£¡£Ëæ×ÅÁ´³¤µÄÔöÌí£¬£¬£¬£¬£¬£¬ÊèË®ÇøÓòµÄ¾ÞϸҲ»áÔöÌí£¬£¬£¬£¬£¬£¬ÕâÒâζ×ų¤Á´Ö¬·¾Ëá¿ÉÄÜÐγɸü´óµÄÊèË®ÇøÓò£¬£¬£¬£¬£¬£¬´Ó¶ø¸üÈÝÒ×Á¬ÏµºÍЯ´ø¸ü¶àµÄÇ×Ö¬ÓªÑøËØ¡£¡£½ºÊø»¯ÔÚÓªÑøËØµÄÎüÊÕÖÐÆðµ½Òªº¦×÷Ó㬣¬£¬£¬£¬£¬ÓÉÓÚËüʹµÃÇ×Ö¬ÓªÑøËØ´ÓʳÎïÖÐÊͷŲ¢±»°ü¹üÔÚ½ºÊøÖУ¬£¬£¬£¬£¬£¬½ø¶ø¸üÈÝÒ×±»Ð¡³¦ÉÏÆ¤Ï¸°ûµÄĤÎüÊÕ¡£¡£


5.ÓªÑøËØµÄ´úлºÍÎüÊÕ

  ÓªÑøËØ£¬£¬£¬£¬£¬£¬ÈçÖ¬ÈÜÐÔάÉúËØ¡¢ÀàºúÂܲ·ËغͶà·Ó£¬£¬£¬£¬£¬£¬Í¨¹ý±»¶¯À©É¢»òÔØÌå½éµ¼µÄ»úÖÆ±»ÎüÊÕ¡£¡£ÕâÐ©ÓªÑøËØÔÚ½øÈëС³¦ÉÏÆ¤Ï¸°ûºó¿ÉÄÜ»áÂÄÀúһϵÁеĴúлÀú³Ì£¬£¬£¬£¬£¬£¬ÆäÖÐÒ»Ð©ÓªÑøËØºÍËüÃǵĴúлÎï¿ÉÄÜ»áͨ¹ýÌØ¶¨µÄתÔËÂѰף¨ÀýÈçP-gp, MRP2, BCRPµÈ£©±»ÔËÊ仨µ½³¦Ç»ÖС£¡£
ÓªÑøËØ·Ö×Óͨ¹ýС³¦Ãž²Âö±»ÎüÊպ󣬣¬£¬£¬£¬£¬Ê×ÏÈÔÚ¸ÎÔྭÓÉÊ×¹ýЧӦ¡£¡£ÔÚÕâ¸öÀú³ÌÖУ¬£¬£¬£¬£¬£¬ÓªÑøËØ¿ÉÄÜ»áÂÄÀúһϵÁеĻ¯Ñ§×ª»¯£¬£¬£¬£¬£¬£¬ÕâÊÇÓɸÎÔàµÄPhase IºÍIIøÍê³ÉµÄ¡£¡£ÕâÒ»´úлÀú³Ì¹ØÓÚijЩÉãÈëÎïÖʵĽⶾºÜÊÇÖ÷Òª£¬£¬£¬£¬£¬£¬ÓÉÓÚËü¿ÉÒÔÒÖÖÆÎüÊÕ¡¢Ôö½øÉøÍ¸£¬£¬£¬£¬£¬£¬²¢ïÔÌ­ÉúÎï»îÐÔ¡£¡£
ԼĪ90%µÄ³¤Á´Ö¬·¾ËáºÍÉÙÁ¿µÄÖÐÁ´Ö¬·¾ËáÔÚÉÏÆ¤Ï¸°ûÖб»×é×°³ÉTAGs£¬£¬£¬£¬£¬£¬È»ºóÐγɵ¨¹Ì´¼Î¢Á£µÄÊèË®ºË£¬£¬£¬£¬£¬£¬ÕâЩ΢Á£±»Êͷŵ½³¦ÁܰÍÖС£¡£ÕâÒ»Àú³ÌÉæ¼°ÄÚÖÊÍøºÍ¸ß¶û»ùÌåÖ®¼äµÄЭ×÷£¬£¬£¬£¬£¬£¬²¢Éæ¼°µ½ÖîÈçÔØÖ¬ÂѰ×B48£¨apoB48£©¡¢ÔØÖ¬ÂѰ×AI£¨apoAI£©µÈµÄÖ¬ÂѰס£¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDcvYzhiNDNhZGUyODBiYTgwNzVjNDI5NGE5MmU4ZTAxNzQucG5n

ÉãÈ¡ºÍʹÓÃÇ×Ö¬ÐÔÓªÑø±£½¡Æ·µÄ¿ÉÄÜÐÔ;¾¶


  ×ܽá

  ÓªÑøÈé¼ÁÔÚ¿Ú·þºóÔÚ賦µÀµÄ´¦ÀíÀú³Ì¹ØÓÚÃ÷È·ÓªÑøÎïÖʵÄÉúÎïʹÓöȾßÓÐÖ÷ÒªÒâÒå¡£¡£Èé¼ÁÔÚ¿ÚÇ»µÄ¶ÌÔÝÍ£ÁôÓëÆäÔÚС³¦µÄÏû»¯ºÍÎüÊÕÀú³ÌÇ×½üÏà¹Ø¡£¡£Èé¼ÁÔÚθºÍС³¦ÖеÄÏû»¯ÇéÐΡ¢ÎïÀí»¯Ñ§×ª±ä¡¢ÒÔ¼°ÓëÏû»¯Ã¸µÄ»¥¶¯¶¼Ó°ÏìÁËÓªÑøËØµÄÊͷźÍÎüÊÕ¡£¡£½ºÊø»¯Àú³Ì½øÒ»²½Ôö½øÁËÇ×Ö¬ÓªÑøËØµÄÁ¬ÏµºÍÊÍ·Å£¬£¬£¬£¬£¬£¬¶øÓªÑøËصĴúлºÍÎüÊÕÉæ¼°ÁËС³¦ºÍ¸ÎÔàµÄ¶à¸öÖØ´óÀú³Ì¡£¡£

Ëæ×ÅÄÉÃ×ÊÖÒÕºÍÉúÎïÊÖÒÕµÄǰ½ø£¬£¬£¬£¬£¬£¬Èé¼ÁÖÆ±¸ÊÖÒÕÕý³¯ÏòÌá¸ßÓªÑøËØµÄÎȹÌÐÔºÍÉúÎïʹÓöÈÉú³¤¡£¡£ÓÅ»¯Èé¼ÁµÄÎïÀí»¯Ñ§ÐÔ×Ó£¬£¬£¬£¬£¬£¬ÈçÒºµÎ¾ÞϸºÍÈ黯¼ÁÀàÐÍ£¬£¬£¬£¬£¬£¬ÊÇÌá¸ßÉúÎïʹÓöȵÄÒªº¦¡£¡£Í¬Ê±£¬£¬£¬£¬£¬£¬È·±£ÓªÑøÈé¼ÁµÄÇå¾²ÐÔ£¬£¬£¬£¬£¬£¬ÌØÊâÊÇÆäºã¾ÃÉãÈëµÄÓ°Ï죬£¬£¬£¬£¬£¬Ò²ÈÕÒæÊܵ½ÖØÊÓ¡£¡£


  ²Î¿¼ÎÄÏ×£º

[1] X. Chen, Y. Chen, Y. Liu, L. Zou, D. J. McClements, and W. Liu, “A review of recent progress in improving the bioavailability of nutraceutical-loaded emulsions after oral intake,” Compr. Rev. Food Sci. Food Saf., vol. 21, no. 5, pp. 3963–4001, 2022, doi: 10.1111/1541-4337.13017.

[2] A. C. Pinheiro, R. F. S. Gonçalves, D. A. Madalena, and A. A. Vicente, “Towards the understanding of the behavior of bio-based nanostructures during in vitro digestion,” Curr. Opin. Food Sci., vol. 15, pp. 79–86, 2017, doi: https://doi.org/10.1016/j.cofs.2017.06.005.

]]>
/?feed=rss2&p=40230 0
ºÀÃŹú¼Ê X ÄÔ´ÎÔª ÏàÖúÐÂÆª ¹²Ó®Î´À´ /?p=40275 /?p=40275#comments Fri, 08 Aug 2025 08:46:48 +0000 http://www.jialanhai.com/?p=40275

ÉÅʳGABAµÄÉñÃØÊµÁ¦£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³×

2025-09-30 14:06


2025Äê7ÔÂ11ÈÕ£¬£¬£¬£¬£¬£¬ºÀÃŹú¼ÊÓëÕã½­ÄÔ´ÎÔª¿Æ¼¼ÓÐÏÞ¹«Ë¾Õ½ÂÔÏàÖúǩԼÒÇʽÔÚÉϺ£IBP¹ú¼Ê¾Û»áÖÐÐľÙÐС£¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvMmZiYzM4NWQ3MjVmMGE4MjdhOTRmNjIzZWEzYmU3ZTUuanBn
Ç©ÊðÕ½ÂÔÏàÖúЭÒé

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvYTU2MzBhMmJiZmNmOWFhNjY2NzA3ZWNlNWNiOTdiNzUuanBn
Ðû²¼Ç©Ô¼ÀÖ³É

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDgvMjkxMjg5YWM4ZGU3MTdkZjY1Nzk1NmFiZWNmNzY1N2YuanBn
½»Á÷ǩԼЭÒé

ÄÔ´ÎÔª½ð×ܼ°ÍŶÓÒ»ÐÐר³Ì¸Ïµ½ºÀÃŹú¼ÊÉϺ£×ܲ¿£¬£¬£¬£¬£¬£¬ÂÃÐÐÁËÐÂÆ·Ð§¹ûչʾ¡£¡£ºÀÃŹú¼ÊÄÉÃ×ÊÖÒÕËï×ܳöϯǩԼÒÇʽ²¢È«³Ì½Ó´ýÁËÄÔ´ÎÔªÍŶÓ¡£¡£Ë«·½½«ÁªºÏÍÆ¶¯½â¾öѹÁ¦¡¢½¹ÂÇ¡¢ÒÖÓô¡¢Ê§ÃßµÈÇéÐ÷ÖÎÀí²úÆ·µÄÉÏÊС£¡£Î´À´ÒÑÀ´£¬£¬£¬£¬£¬£¬Á¢ÒìǰÐУ¡


·ÖÏíµ½£º

ÔĶÁ¸ü¶àÎÄÕÂ
READ MORE

]]>
/?feed=rss2&p=40304 0
¡¶Free Radical Research¡·£ºÍʺÚËØÖúÎÒÃÇ·´¿¹¡°Ñõ»¯Ñ¹Á¦¡±£¡ /?p=40220 /?p=40220#comments Fri, 27 Jun 2025 07:58:00 +0000 http://www.jialanhai.com/?p=40220
¡¶Free Radical Research¡·£ºÍʺÚËØÖúÎÒÃÇ·´¿¹“Ñõ»¯Ñ¹Á¦”£¡

   ÄãÖªµÀÂ𣬣¬£¬£¬£¬£¬ÍʺÚËØµÄÔö²¹¿ÉÒÔÔöÇ¿ÔË·¢¶¯ÔÚ¸ßÇ¿¶ÈѵÁ·Ê±´úµÄ¿¹Ñõ»¯ÄÜÁ¦£¬£¬£¬£¬£¬£¬²¢ïÔÌ­Ñ×֢״̬¡£¡£

   ½üÆÚ½ÒÏþÔÚFree Radical ResearchÔÓÖ¾ÉϵÄһƪÂÛÎÄ·¢Ã÷£¬£¬£¬£¬£¬£¬ÍʺÚËØÔö²¹µ¼ÖÂÔË·¢¶¯µÄÑõ»¯Ó¦¼¤±ê¼ÇÎïÏÔÖøïÔÌ­£¬£¬£¬£¬£¬£¬²¢ÔöÇ¿ÁË¿¹Ñõ»¯Ã¸µÄ»îÐÔ[1]¡£¡£Êý¾Ý½øÒ»²½ÏÔʾ£¬£¬£¬£¬£¬£¬¸ßÇ¿¶ÈѵÁ·µÄרҵÔË·¢¶¯ÌåÄÚµÄÑõ»¯Ó¦¼¤ºÍÑ×Ö¢Àú³ÌÔöÌí£¬£¬£¬£¬£¬£¬µ«ÍʺÚËØÔö²¹¿ÉÄÜÓÐÖúÓÚ±£»£»£»£»£»£»¤×éÖ¯ÃâÊܲ»Á¼Ó°Ïì¡£¡£

   ÆäÖУ¬£¬£¬£¬£¬£¬ÍʺÚËØÔö²¹ºó£¬£¬£¬£¬£¬£¬×ãÇòÔË·¢¶¯µÄÍʺÚËØºÍÒìǰÏßÏÙËØÅ¨¶È¾ùÏÔÖøµÍÓÚ±ÈÕÕ×飬£¬£¬£¬£¬£¬¶ø»®´¬ÔË·¢¶¯µÄ»¹Ô­Ð͹Èë׸ÊëÄ(GSH)Ũ¶ÈÓë±ÈÕÕ×é¿¿½üµ«¸ßÓÚ×ãÇòÔË·¢¶¯¡£¡£

   ¿´À´£¬£¬£¬£¬£¬£¬ÍʺÚËØÔö²¹ÄÜÏÔÖøµ÷ÀíÔË·¢¶¯µÄÑõ»¯Ó¦¼¤ºÍÑ×Ö¢±ê¼ÇÎï¡£¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDYvMWUwNGEyYjE0YzIzNjJmODhlN2MxNmQwYzBjZDhiYTgucG5n

ÂÛÎÄÊ×Ò³½ØÍ¼


   ¸ßÇ¿¶ÈµÄÌåÓýÄ¥Á¶ºÍѵÁ·»áµ¼ÖÂÔË·¢¶¯ÌåÄÚ·ºÆðÑõ»¯Ó¦¼¤ºÍÑ×Ö¢±ê¼ÇÎï¡£¡£µ±ÉíÌå¾ÙÐиßÇ¿¶ÈµÄÔ˶¯Ê±£¬£¬£¬£¬£¬£¬»áÔöÌíÑõµÄÉãÈ¡ºÍʹÓ㬣¬£¬£¬£¬£¬´Ó¶øÔöÌíÌåÄÚ×ÔÓÉ»ùµÄ±¬·¢¡£¡£

   ¼ÈÈ»ÔÆÔÆ£¬£¬£¬£¬£¬£¬ÊÇ·ñͨ¹ý´ÓÔö²¹ÍʺÚËØ£¬£¬£¬£¬£¬£¬ÔÚÑõ»¯Ó¦¼¤ºÍÑ×Ö¢·´Ó³ÉÐδ¼Ó¾çʱ£¬£¬£¬£¬£¬£¬ïÔÌ­±¬·¢ÕâЩ±ê¼ÇÎïÄØ£¿£¿

   Ñо¿ÕßÕÐļÁË81ÃûÄÐÐÔ¼ÓÈëÕߣ¬£¬£¬£¬£¬£¬ÆäÖÐ47Ãû×ãÇòÔË·¢¶¯¡¢19Ãû»®´¬ÔË·¢¶¯ºÍ15Ãû²»¾ÙÐÐÌåÓýÄ¥Á¶µÄÇàÄêÄÐÐÔ×÷Ϊ±ÈÕÕ×é¡£¡£ÎªÁËÈ·±£Ñо¿µÄ׼ȷÐÔ£¬£¬£¬£¬£¬£¬ÕâЩ¼ÓÈëÕß¶¼Ã»Óоƾ«ºÍ/»òÑ̲ݳÉñ«¡¢ÌÇÄò²¡¡¢Ô­·¢ÐÔ¸ßѪѹ¡¢È±ÑªÐÔÐÄÔಡ¡¢ÖзçºÍÉö¹¦Ð§Ë¥½ßµÈÒÑÖªµÄ×ÔÓÉ»ù²¡Òò¡£¡£ÔÚ¾ÙÐÐÍʺÚËØÔö²¹Ö®Ç°£¬£¬£¬£¬£¬£¬ËùÓÐÔË·¢¶¯¶¼¾­ÓÉÁËΪÆÚ30ÌìµÄ½ÇÖð×¼±¸ÆÚ£¬£¬£¬£¬£¬£¬²¢¾ÙÐÐÁËһϵÁеÄËÙÂÊ-ÄÍÁ¦ÑµÁ·¡£¡£

   Éú»¯ÆÊÎö°üÀ¨¶ÔѪÇåÖеÄÍʺÚËØ¡¢ÒìǰÏßÏÙËØ¡¢¿¹Ñõ»¯-LDL¿¹Ìå¡¢IL-6ºÍCRPµÄŨ¶È¾ÙÐÐøÃâÒ߲ⶨ£¬£¬£¬£¬£¬£¬ÒÔ¼°Ê¹ÓÃBeutlerµÄÒªÁì¶Ôºìϸ°ûÖеĻ¹Ô­Ð͹Èë׸ÊëÄ£¨GSH£©µÄŨ¶È¾ÙÐвⶨ¡£¡£

   Ñо¿Ð§¹ûÒýÈËעĿ£¬£¬£¬£¬£¬£¬ÓëÑõ»¯Ó¦¼¤ºÍÑ×Ö¢±ê¼ÇÎïÏÔÖøÏà¹ØµÄÉú»¯²ÎÊýÖ÷ÒªÊÇÍʺÚËØ¡¢ÒìǰÏßÏÙËØ¡¢»¹Ô­Ð͹Èë׸ÊëĵÈ¡£¡£ÌØÊâÊÇÔÚ×ãÇòÔË·¢¶¯ºÍ»®´¬ÔË·¢¶¯ÖУ¬£¬£¬£¬£¬£¬ÕâЩ±ê¼ÇÎïµÄŨ¶ÈÓë±ÈÕÕ×é±£´æÏÔÖø²î±ð£¬£¬£¬£¬£¬£¬Åú×¢ÍʺÚËØÔö²¹¶ÔÕâЩ±ê¼ÇÎïÓÐÏÔÖøµÄµ÷Àí×÷Óᣡ£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDYvMzlhMDExNGIxODRjZmM4ZDBmMWE0Mzk2ODFhMTVjMjMucG5n

½ÏÁ¿²î±ðʱ¼äµã±ÈÕÕ×飬£¬£¬£¬£¬£¬×ãÇòÔË·¢¶¯ºÍ»®´¬ÔË·¢¶¯Ö®¼äµÄѪÇåÍʺڼ¤ËØÅ¨¶È


   ÑªÇåÖеÄÍʺÚËØÅ¨¶ÈÔÚ²î±ðʱ¼äµãÔÚ±ÈÕÕ×é¡¢×ãÇòÔË·¢¶¯ºÍ»®´¬ÔË·¢¶¯Ö®¼ä±£´æÏÔÖø²î±ð¡£¡£×ãÇòÔË·¢¶¯µÄÍʺÚËØÅ¨¶ÈÔÚ½ÇÖðºóÏÔÖøÏ½µ£¬£¬£¬£¬£¬£¬¶ø»®´¬ÔË·¢¶¯µÄŨ¶ÈÔÚ½ÇÖðºóÂÔÓÐÉÏÉý¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬±ÈÕÕ×éµÄÍʺÚËØÅ¨¶ÈÔÚÕû¸öÑо¿Ê±´úÏà¶ÔÎȹÌ¡£¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDYvM2I1NTNiMjAwMDU5MzM4YzU0ZWE1MGI1YmUxZDRjZjkucG5n

½ÏÁ¿²î±ðʱ¼äµã±ÈÕÕ×飬£¬£¬£¬£¬£¬×ãÇòÔË·¢¶¯ºÍ»®´¬ÕßÖ®¼äµÄºìϸ°û½µµÍ¹Èë׸ÊëÄ£¨GSH£©Å¨¶È


   ±ÈÕÕ×é¡¢×ãÇòÔË·¢¶¯ºÍ»®´¬ÔË·¢¶¯µÄGSHŨ¶È»®·ÖΪ2.64 ± 0.25 mmol/L¡¢2.43 ± 0.28 mmol/LºÍ2.73 ± 0.27 mmol/L¡£¡£×ãÇòÔË·¢¶¯µÄGSHŨ¶ÈÏà¶Ô½ÏµÍ£¬£¬£¬£¬£¬£¬¶ø»®´¬ÔË·¢¶¯µÄGSHŨ¶ÈÓë±ÈÕÕ×éÏà½ü¡£¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDYvYjZkNzQxYmI1ZDE1YmQxOTVjYTNmMGZlYTdlZjhmYzQucG5n

½ÏÁ¿²î±ðʱ¼äµã±ÈÕÕ×飬£¬£¬£¬£¬£¬×ãÇòÔË·¢¶¯ºÍ»®´¬ÔË·¢¶¯Ö®¼äµÄѪÇåÒìǰÏßËØÅ¨¶È


   ÔÚ²î±ðʱ¼äµã£¬£¬£¬£¬£¬£¬×ãÇòÔË·¢¶¯¡¢»®´¬ÔË·¢¶¯ºÍ±ÈÕÕ×éÖ®¼äµÄѪÇåÒìǰÏßÏÙËØÅ¨¶È±£´æÏÔÖø²î±ð¡£¡£×ãÇòÔË·¢¶¯µÄŨ¶ÈÔÚ½ÇÖðºóϽµÖÁ625 ± 244 pg/mL£¬£¬£¬£¬£¬£¬¶ø»®´¬ÔË·¢¶¯µÄŨ¶ÈÎȹÌÔÚ676 ± 299 pg/mL¡£¡£²»¹ý£¬£¬£¬£¬£¬£¬ÕâÁ½×éÔË·¢¶¯µÄÒìǰÏßÏÙËØÅ¨¶È¾ù¸ßÓÚ±ÈÕÕ×é¡£¡£


   ¹ØÓÚ»úÖÆ£¬£¬£¬£¬£¬£¬ÍʺÚËØ¼°Æä´úл²úÆ·¿ÉÒÔÖ±½Óɨ³ý»îÐÔÑõºÍµª£¨RONS£©£¬£¬£¬£¬£¬£¬ÕâÒ»Àú³Ì±»³ÆÎª×ÔÓÉ»ùɨ³ý¼¶Áª£¬£¬£¬£¬£¬£¬Ê¹ÍʺÚËØÓëÆäËû¿¹Ñõ»¯¼ÁÓÐËùÇø±ð¡£¡£ÍʺÚËØµÄ¼ä½Ó¿¹Ñõ»¯»îÐÔÓëÆäͨ¹ýµ÷Àíø»îÐÔ»ò»ùÒò±í´ïÀ´´Ì¼¤¿¹Ñõ»¯Ã¸£¨È糬Ñõ»¯ÎïÆç»¯Ã¸¡¢¹Èë׸ÊëĹýÑõ»¯ÎïøºÍ¹ýÑõ»¯Çâø£©µÄ»îÐÔÓйØ¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬ÍʺÚËØ»¹¼ÓÈëά³Ö¸ßŨ¶ÈµÄ»¹Ô­Ð͹Èë׸ÊëÄ£¨GSH£©£¬£¬£¬£¬£¬£¬ÓÉÓÚÕâÖÖßÅßá°·À໯ºÏÎï¿ÉÒÔÓÕµ¼GSHºÏ³ÉµÄËÙÂÊÏÞÖÆÃ¸γ-¹È°±õ£ë×°±ËáºÏøµÄ»îÐÔ¡£¡£


   Ò²¾ÍÊÇ˵£¬£¬£¬£¬£¬£¬ÍʺÚËØ¿ÉÄÜ×ÊÖúÎÒÃÇïÔÌ­Á˲¿·Ö´ÙÑס¢´ÙÖ¬ÖʹýÑõ»¯µÄ»îÐÔÑõºÍµª¡£¡£


   ±¾Ñо¿Õ¹ÏÖÁËÍʺÚËØÔÚµ÷ÀíÔ˶¯ºóµÄÑõ»¯Ó¦¼¤ºÍÑ×Ö¢·´Ó³ÖеÄÖ÷Òª×÷Óᣡ£Ñо¿ÕßÒÔΪ£¬£¬£¬£¬£¬£¬ÍʺÚËØ¼°Æä´úл²úÆ·ÓÐÍû³ÉΪÔË·¢¶¯ºÍÆäËûÈËȺÖÐïÔÌ­Ñõ»¯ËðÉ˺ÍÑ×Ö¢µÄÓÐÓÃÊֶΡ£¡£µ«ÒªÊµÏÖÕâһĿµÄ£¬£¬£¬£¬£¬£¬ÎÒÃÇ»¹ÐèÒª¸üÉîÈëµØÑо¿Æä×÷ÓûúÖÆ£¬£¬£¬£¬£¬£¬²¢Í¨¹ý¸ü¶àµÄÁÙ´²ÊÔÑéÀ´ÑéÖ¤ÆäЧ¹û¡£¡£


   ²Î¿¼ÎÄÏ×£º

    [1] J. Czuczejko, ?. Sielski, B. Wo?niak, A. Wo?niak, and K. Szewczyk-Golec, “Melatonin supplementation improves oxidative and inflammatory state in the blood of professional athletes during the preparatory period for competitions,” Free Radic. Res., vol. 53, no. 2, pp. 198–209, 2019, doi: 10.1080/10715762.2018.1563688.

]]>
/?feed=rss2&p=40220 0
άÉúËØB12ÓëÔË·¢¶¯µÄºìϸ°û£ºÒ»ÏîÐÂÑо¿Õ¹ÏÖÁËÁ½ÕßÖ®¼äµÄ¹ØÏµ /?p=40184 /?p=40184#comments Tue, 27 May 2025 03:14:25 +0000 http://www.jialanhai.com/?p=40184

ÉÅʳGABAµÄÉñÃØÊµÁ¦£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³×

2025-09-30 14:06

   Î¬ÉúËØB12ÔÚÈËÌåÖеÄÁ½ÖÖÉúÎï»îÐÔÐÎʽÓëºìϸ°ûµÄÐγÉÓйØ£¬£¬£¬£¬£¬£¬Õâ¶ÔÔË·¢¶¯µÄÌåÏÖÖÁ¹ØÖ÷Òª¡£¡£Ö»¹ÜάÉúËØB12ÔÚÔ˶¯ÁìÓòÖÐÊܵ½ÆÕ±é¹Ø×¢£¬£¬£¬£¬£¬£¬µ«¹ØÓÚÆäÓëÔ˶¯ÌåÏÖÖ®¼ä¼òÖ±ÇйØÏµµÄÑо¿ÈÔÈ»ÓÐÏÞ¡£¡£ÈÕǰ£¬£¬£¬£¬£¬£¬²¨À¼µÄ¿ÆÑÐÖ°Ô±ÔÚNutrientsÔÓÖ¾½ÒÏþÁËÐÂÑо¿°¸Àý£¬£¬£¬£¬£¬£¬Åú×¢½¨ÒéÔË·¢¶¯Ó¦¼á³ÖάÉúËØB12Ũ¶ÈÔÚ400-700 pg/mL¹æÄ£ÄÚÒÔÓÅ»¯ºìϸ°û²ÎÊý£¬£¬£¬£¬£¬£¬ÇÒŨ¶ÈµÍÓÚ400 pg/mLµÄÔË·¢¶¯¿ÉÄÜÐèÒªÔö²¹Î¬ÉúËØB12[1]¡£¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDUvZjI3ODE4MGE4OWUxMzVmZmE2NmNjMzM2MjY0MGQzNTYucG5n


1.άÉúËØB12£º²»µ«½öÊÇÒ»¸öάÉúËØ


   Î¬ÉúËØB12£¬£¬£¬£¬£¬£¬ÊÇÒ»ÖÖË®ÈÜÐÔάÉúËØ£¬£¬£¬£¬£¬£¬¹ØÓÚÈËÌåµÄ¿µ½¡ºÍ¹¦Ð§ÖÁ¹ØÖ÷Òª¡£¡£ÔÚÉúÎﻯѧ²ãÃæ£¬£¬£¬£¬£¬£¬Ëü×÷ΪijЩҪº¦Ã¸µÄ¸¨Ã¸£¬£¬£¬£¬£¬£¬¼ÓÈëÁ˶àÖÖÉúÎﻯѧ·´Ó³£¬£¬£¬£¬£¬£¬°üÀ¨DNAºÏ³É¡¢Ö¬·¾ºÍ°±»ùËáµÄ´úлÒÔ¼°Éñ¾­ÇÊÖ¬µÄÉú²ú¡£¡£ÌØÊâÊÇÔÚºìϸ°ûµÄÌìÉúÖУ¬£¬£¬£¬£¬£¬Î¬ÉúËØB12Æðµ½Á˲»¿É»òȱµÄ×÷Óᣡ£ºìϸ°ûÈÏÕæ½«ÑõÆø´Ó·Î²¿ÔËË͵½ÉíÌåµÄ¸÷¸ö²¿Î»£¬£¬£¬£¬£¬£¬Õâ¹ØÓÚËùÓÐÈË£¬£¬£¬£¬£¬£¬ÓÈÆäÊÇÔË·¢¶¯À´Ëµ£¬£¬£¬£¬£¬£¬¶¼ÊÇÖÁ¹ØÖ÷ÒªµÄ¡£¡£Ò»¸ö¿µ½¡µÄºìϸ°û¼ÆÊý¿ÉÒÔÈ·±£ÉíÌå×éÖ¯»ñµÃ¸»×ãµÄÑõÆø£¬£¬£¬£¬£¬£¬´Ó¶øÎ¬³ÖÆä¹¦Ð§²¢Ö§³ÖÉíÌåµÄ»î¶¯¡£¡£

2.ÔË·¢¶¯ÎªºÎÌåÌùάÉúËØB12


   ¹ØÓÚÔË·¢¶¯À´Ëµ£¬£¬£¬£¬£¬£¬Î¬ÉúËØB12µÄÖ÷ÒªÐÔ¸üÊDz»ÑÔ¶øÓ÷¡£¡£Ê×ÏÈ£¬£¬£¬£¬£¬£¬Ëü¹ØÓÚÄÜÁ¿´úлÖÁ¹ØÖ÷Òª¡£¡£ÔË·¢¶¯ÐèÒª´ó×ÚµÄÄÜÁ¿À´Ö§³ÖËûÃǵÄѵÁ·ºÍ½ÇÖ𣬣¬£¬£¬£¬£¬¶øÎ¬ÉúËØB12ÔÚ×ÊÖúÉíÌå´ÓʳÎïÖÐÌáÈ¡ÄÜÁ¿µÄÀú³ÌÖÐÆðµ½ÁËÒªº¦×÷Óᣡ£±ðµÄ£¬£¬£¬£¬£¬£¬Î¬ÉúËØB12¹ØÓÚÉñ¾­ÏµÍ³µÄ¿µ½¡Ò²ºÜÊÇÖ÷Òª¡£¡£Ò»¸ö¿µ½¡µÄÉñ¾­ÏµÍ³¿ÉÒÔÈ·±£Éñ¾­ÐźŵĿìËÙºÍ׼ȷ´«Ê䣬£¬£¬£¬£¬£¬Õâ¹ØÓÚÔË·¢¶¯µÄ·´Ó³ËÙÂʺÍЭµ÷ÐÔÖÁ¹ØÖ÷Òª¡£¡£×îºó£¬£¬£¬£¬£¬£¬Î¬ÉúËØB12»¹ÓëÃâÒßϵͳµÄ¿µ½¡ÓйØ¡£¡£¸ßÇ¿¶ÈµÄѵÁ·ºÍ½ÇÖð¿ÉÄÜ»á¶ÔÃâÒßϵͳÔì³ÉѹÁ¦£¬£¬£¬£¬£¬£¬¶øÊÊÁ¿µÄάÉúËØB12ÉãÈë¿ÉÒÔ×ÊÖúÔË·¢¶¯Î¬³ÖÃâÒßϵͳµÄ¿µ½¡£¬£¬£¬£¬£¬£¬´Ó¶øïÔÌ­Òò¼²²¡µ¼ÖµÄѵÁ·ºÍ½ÇÖðÖÐÖ¹¡£¡£

3.×îÐÂÑо¿Êý¾Ý


   ¿ËÈÕ£¬£¬£¬£¬£¬£¬NutrientsÔÓÖ¾ÉϽÒÏþÁËһƪÓɲ¨À¼²¨×ÈÄÏ´óѧҽѧ¿ÆÑ§Ñ§ÔºµÄÑо¿ÍŶÓ׫дµÄÎÄÕ£¬£¬£¬£¬£¬£¬ÉîÈë̽ÌÖÁËάÉúËØB12ÓëÔË·¢¶¯ºìϸ°ûÖ®¼äµÄ¹ØÏµ¡£¡£ÔÚÕâÏîÑо¿ÖУ¬£¬£¬£¬£¬£¬¶Ô243ÃûÌï¾¶ÔË·¢¶¯µÄѪҺÑù±¾¾ÙÐÐÁËÆÊÎö£¬£¬£¬£¬£¬£¬ÒÔ̽ÌÖάÉúËØB12Ũ¶ÈÓëÔ˶¯ÌåÏÖÖ®¼äµÄ¹ØÏµ¡£¡£

   ËùÓÐÊÜÊÔÕߵį½¾ùάÉúËØB12Ũ¶ÈΪ739 ¡À 13 pg/mL¡£¡£ÊµÁ¦ÐÍÔË·¢¶¯µÄŨ¶ÈΪ703 ¡À 15 pg/mL£¬£¬£¬£¬£¬£¬¶øÄÍÁ¦ÐÍÔË·¢¶¯µÄŨ¶ÈΪ881 ¡À 32 pg/mL£¬£¬£¬£¬£¬£¬ÏÔʾÄÍÁ¦ÐÍÔË·¢¶¯µÄάÉúËØB12Ũ¶ÈÏÔÖø¸ßÓÚʵÁ¦ÐÍÔË·¢¶¯¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬ÊµÁ¦ÔË·¢¶¯µÄάÉúËØB12Ũ¶ÈµÍÓÚ300, 350ºÍ400 pg/mLµÄÑù±¾ÊýÄ¿ÏÔ×ŶàÓÚÄÍÁ¦ÔË·¢¶¯£¬£¬£¬£¬£¬£¬¶øÁè¼Ý700 pg/mLµÄŨ¶ÈÔÚÄÍÁ¦ÔË·¢¶¯ÖиüΪ³£¼û¡£¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDUvMTkwNmUwN2UxYzQ0YmUyOGNkYWQxNjQ4YTQ4ZTY2MzcucG5n

ͼ1£ºÊµÁ¦ÐͺÍÄÍÁ¦ÐÍÔË·¢¶¯ÖУ¬£¬£¬£¬£¬£¬Î¬ÉúËØB12Ũ¶ÈµÍÓÚ300¡¢350ºÍ400 pg/mLÒÔ¼°¸ßÓÚ700 pg/mLµÄÑù±¾ÊýÄ¿ºÍ°Ù·Ö±È¡£¡£


   ¸üΪÖ÷ÒªµÄÊÇ£¬£¬£¬£¬£¬£¬Ñо¿»¹·¢Ã÷ÁËѪºìÂѰ×Ũ¶ÈÓëάÉúËØB12Ũ¶ÈÖ®¼äµÄ¹ØÏµ¡£¡£ÑªºìÂѰ×ÊǺìϸ°ûÖеÄÒ»¸öÒªº¦ÂѰ×ÖÊ£¬£¬£¬£¬£¬£¬ÈÏÕæÐ¯´øÑõÆø¡£¡£Ñо¿ÏÔʾ£¬£¬£¬£¬£¬£¬Î¬ÉúËØB12Ũ¶È½Ï¸ßµÄÔË·¢¶¯£¬£¬£¬£¬£¬£¬ÆäѪºìÂѰ×Ũ¶ÈÒ²ÏìÓ¦½Ï¸ß£¬£¬£¬£¬£¬£¬ÕâÒâζ×ÅËûÃǵÄÑõÆøÔËËÍÄÜÁ¦¿ÉÄܸüÇ¿¡£¡£

   ¹ØÓÚºìϸ°û²ÎÊý£¬£¬£¬£¬£¬£¬Ñо¿·¢Ã÷άÉúËØB12ÓëѪºìÂѰ×Ũ¶È¡¢ÑªÏ¸°û±ÈÈÝ¡¢Æ½¾ùϸ°ûÌå»ý£¨MCV£©Çå¾²¾ùϸ°ûѪºìÂѰף¨MCH£©Ö®¼ä±£´æÈõµ«Í³¼ÆÑ§ÉÏÏÔÖøµÄÕýÏà¹Ø¹ØÏµ¡£¡£ÕâÒâζ×ÅάÉúËØB12Ũ¶ÈµÄÔöÌí¿ÉÄÜÓëÕâЩºìϸ°û²ÎÊýµÄ¸ÄÉÆÓйØ£¬£¬£¬£¬£¬£¬´Ó¶ø¿ÉÄÜÓ°ÏìÔË·¢¶¯µÄÔ˶¯ÌåÏÖ¡£¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDUvNWQ4ZjkxZGE5OWZmYzc5MWFhNGNlZTk5MzU5ZDMzYzYucG5n

ͼ2£º×ÜѪÇåάÉúËØB12Ũ¶ÈÓëѪҺѧָ±êÖ®¼äµÄÏà¹ØÐÔ£ºÑªºìÂѰ×Ũ¶È¡¢ÑªÏ¸°û±ÈÈÝ¡¢Æ½¾ùϸ°ûÌå»ý£¨MCV£©Çå¾²¾ùϸ°ûѪºìÂѰף¨MCH£©¡£¡£

   ÕâЩÊý¾ÝÕ¹ÏÖÁËάÉúËØB12Ũ¶ÈÓëÔË·¢¶¯µÄÔ˶¯ÀàÐÍÖ®¼äµÄ¹ØÏµ£¬£¬£¬£¬£¬£¬ÒÔ¼°Î¬ÉúËØB12Ũ¶È¶ÔÔ˶¯ÌåÏÖµÄDZÔÚÔöÒæÐ§¹û¡£¡£ÓÈÆäÊÇÔÚÄÍÁ¦Ô˶¯ÖУ¬£¬£¬£¬£¬£¬½Ï¸ßµÄάÉúËØB12Ũ¶È¿ÉÄÜÓë¸üºÃµÄÔ˶¯ÌåÏÖÓйØ¡£¡£

4.½áÂÛ


   ¸ÃÑо¿Ì½ÌÖÁËÔË·¢¶¯ÌåÄÚάÉúËØB12Ũ¶ÈÓëºìϸ°û²ÎÊýÖ®¼äµÄ¹ØÏµ¡£¡£Ð§¹ûÏÔʾ£¬£¬£¬£¬£¬£¬Î¬ÉúËØB12Ũ¶ÈÓëѪºìÂѰ×Ũ¶ÈÖ®¼ä±£´æÕýÏà¹Ø£¬£¬£¬£¬£¬£¬ÇÒµ±Î¬ÉúËØB12Ũ¶ÈΪ488 pg/mLʱ£¬£¬£¬£¬£¬£¬¿ÉÒÔµÖ´ïѪºìÂѰ׵ı¥ºÍˮƽµÄ99%¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬Î¬ÉúËØB12×¢Éä¿ÉÒÔÏÔÖøÌá¸ßѪºìÂѰ×Ũ¶È¡£¡£Òò´Ë£¬£¬£¬£¬£¬£¬½¨ÒéÔË·¢¶¯Î¬³Ö400-700 pg/mLµÄάÉúËØB12Ũ¶È£¬£¬£¬£¬£¬£¬ÒÔÓÅ»¯ºìϸ°û²ÎÊý¡£¡£Î´À´µÄÑо¿Ó¦½øÒ»²½Ì½Ë÷άÉúËØB12ÓëÆäËûÐÄÀíÖ¸±êÖ®¼äµÄ¹ØÏµ£¬£¬£¬£¬£¬£¬ÒÔ¸üÖÜÈ«µØÏàʶÆäÔÚÔ˶¯ÌåÏÖÖеÄ×÷Óᣡ£

²Î¿¼ÎÄÏ×£º

[1] J. Krzywa¨½ski et al., ¡°Vitamin B12 status and optimal range for hemoglobin formation in elite athletes,¡± Nutrients, vol. 12, no. 4, 2020, doi: 10.3390/nu12041038.

·ÖÏíµ½£º

ÔĶÁ¸ü¶àÎÄÕÂ
READ MORE

]]>
/?feed=rss2&p=40304 0
Í»ÆÆCoQ10ÎüÊÕÆ¿¾±£ºÊÍ·ÅÎÞÖ¬ÖÊÄÉÃ×ÖÆ¼ÁµÄDZÄÜ /?p=40159 /?p=40159#comments Mon, 28 Apr 2025 01:46:09 +0000 http://www.jialanhai.com/?p=40159

ÉÅʳGABAµÄÉñÃØÊµÁ¦£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³×

2025-09-30 14:06

   ¸¨Ã¸Q10ÎüÊÕÂʽϵ͵ÄÖ÷ÒªÔ­ÒòÖ®Ò»ÊÇÆäÖ¬ÈÜÐÔÌØÕ÷ÓëÏû»¯µÀÇéÐεIJ»Æ¥Åä¡£¡£Ö¬ÈÜÐÔ·Ö×ÓÔÚË®ÐÔµÄ賦µÀÖÐÄÑÒÔÏûÈÚ£¬£¬£¬£¬£¬£¬´Ó¶øÏÞÖÆÁËÆäÓÐÓÃÎüÊÕ¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬Î¸ËáºÍÒÈÒºµÄ±£´æ¿ÉÄܻᵼÖ¸¨Ã¸Q10µÄ½µ½â£¬£¬£¬£¬£¬£¬Ó°ÏìÆäÉúÎï»îÐÔºÍÎüÊÕЧ¹û¡£¡£Í¬Ê±£¬£¬£¬£¬£¬£¬¸¨Ã¸Q10¿ÉÄÜÓëÆäËûÖ¬ÈÜÐÔÎïÖʾºÕùÎü¸½ÔÚ³¦±ÚÉÏ£¬£¬£¬£¬£¬£¬´Ó¶øÏÞÖÆÁËÆä½øÒ»²½µÄÎüÊÕ¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬³¦ð¤Ä¤µÄÆÁÕϹ¦Ð§Ò²¿ÉÄÜÓ°Ï츨øQ10µÄ´©Í¸¡£¡£

   ÎªÁËսʤÕâЩÏÞÖÆÒòËØ£¬£¬£¬£¬£¬£¬¶«ÄÏ´óѧÑо¿Ö°Ô±ÔÚ¡¶BioMed research international¡··¢ÎÄ¡¶Novel Lipid-Free Nanoformulation for Improving Oral Bioavailability of Coenzyme Q10¡·¶ÔÌá¸ß¸¨Ã¸Q10µÄÉúÎïʹÓöȺÍÎüÊÕЧÂÊÓÐÁ˸ü¶àÖ±¹ÛµÄÏàʶ[1]¡£¡£

1.¸¨Ã¸Q10

   ¸¨Ã¸Q10£¨CoQ10£©ÊÇÏßÁ£ÌåºôÎüÁ´µÄÖ÷Òª×é³É²¿·Ö£¬£¬£¬£¬£¬£¬±£´æÓÚËùÓлîϸ°ûµÄÏßÁ£ÌåÄÚĤÖС£¡£ËüÊÇÓÐÓõĿ¹Ñõ»¯¼Á£¬£¬£¬£¬£¬£¬¿ÉÒÔ·´¿¹×ÔÓÉ»ùºÍÖ¬ÖʹýÑõ»¯¡£¡£Ðí¶àÑо¿±¨¸æÏÔʾ£¬£¬£¬£¬£¬£¬ÔÚÐÄѪ¹Ü¼²²¡¡¢Éñ¾­ÍËÐÐÐÔ¼²²¡¡¢ÌÇÄò²¡¡¢ËûÍ¡ÀàÒ©ÎïÏà¹Ø¼¡ÈâÌÛÍ´ºÍ°©Ö¢»¼ÕßÖб£´æ¸¨Ã¸Q10ȱ·¦¡£¡£Ôö²¹¸¨Ã¸Q10Òѱ»Ö¤Êµ¶ÔÖÎÁÆÕâЩ¼²²¡ÓÐÒæ£¬£¬£¬£¬£¬£¬²¢ÇÒÐí¶àÁÙ´²ÊÔÑéÕýÔÚÊÓ²ìÆä×÷ΪҩÎï»òÉÅʳÔö²¹¼ÁµÄÓ¦Óᣡ£

   ÓÐѧÕßÔÚSelf-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessmentÑо¿ÖÐ֤ʵ£¬£¬£¬£¬£¬£¬¸¨Ã¸Q10Ë®ÈÜÐÔ¼«²î¡¢µÍÉúÎïʹÓöȺÍת´ïÐÔ[2]¡£¡£Òò´Ë£¬£¬£¬£¬£¬£¬Õë¶Ô¸¨Ã¸Q10µÄ¿Ú·þÖÎÁÆ·½°¸ÊÇ»ùÓÚÆä×Ô¼ºµÄÖ¬ÈÜÐÔ£¬£¬£¬£¬£¬£¬ÍƼöÓ븻º¬Ö¬ÖʵÄʳÎïͬʱ·þÓᣡ£

2.Ìá¸ß¸¨Ã¸Q10µÄÉúÎïʹÓöÈ

   Í¨Ë׸¨Ã¸Q10µÄÉúÎïʹÓöÈÏà¶Ô½ÏµÍ£¬£¬£¬£¬£¬£¬×ÝÈ»ÔÚÅäºÏ¸»º¬Ö¬ÖʵÄʳÎïͬʱ·þÓ㬣¬£¬£¬£¬£¬ÆäÎüÊÕÂÊÒ²Ö»ÓÐÔ¼3%[3]¡£¡£ÕâÊÇÓÉÓÚ¸¨Ã¸Q10ÊÇÖ¬ÈÜÐԵ쬣¬£¬£¬£¬£¬²¢ÇÒÔÚÌåÄÚµÄÎüÊÕºÍʹÓÃÊܵ½¶àÖÖÒòËØµÄÓ°Ï죬£¬£¬£¬£¬£¬°üÀ¨Æä×Ô¼ºµÄ»¯Ñ§ÐÔ×Ó¡¢Î¸³¦µÀµÄÐÄÀíÇéÐΡ¢ÒûʳÒòËØµÈ¡£¡£ÏÖÔÚ£¬£¬£¬£¬£¬£¬³¯×Å¿ª·¢Ò»ÖÖº¬ÓÐÍâò»îÐÔ¼ÁµÄ¸ßÎüÊÕ¸¨Ã¸Q10ÄÉÃ×ÖÆ¼ÁµÄÆ«ÏòÂõ½øÒѳÉΪδÀ´µÄÉú³¤Ç÷ÊÆ¡£¡£

   ¶«ÄÏ´óѧµÄÑо¿ÍŶÓÔÚ¡¶BioMed Research International¡·ÔÓÖ¾ÉϽÒÏþµÄÂÛÎÄ¡¶Novel Lipid-Free Nanoformulation for Improving Oral Bioavailability of Coenzyme Q10¡·ÖÐÕ¹ÏÖ£¬£¬£¬£¬£¬£¬Í¨¹ýÎȹÌÍâò»îÐÔ¼ÁµÄÎÞÖ¬ÖÊÄÉÃ×CoQ10ϵͳ£¬£¬£¬£¬£¬£¬¿ÉÄܳÉΪÌá¸ß¿Ú·þCoQ10ÉúÎïʹÓöȵÄÓÐÓÃÔØÌå¡£¡£

ºÀÃŹú¼Ê¡¤(Öйú¼¯ÍÅ)¹Ù·½ÍøÕ¾

   Ñо¿½ÓÄɸßÄÜÒªÁìºÍ¸ßѹ¾ùÖÊ»úÖÆ±¸ÁËÄÉÃ×CoQ10ÖÆ¼Á¡£¡£Ã¿ÖÖÄÉÃ×CoQ10ÖÆ¼Á¶¼¾­ÓÉÍâò»îÐÔ¼ÁÎȹÌ£¬£¬£¬£¬£¬£¬ÕâЩÍâò»îÐÔ¼Á¾ßÓвî±ðµÄÇ×Ë®»ùÍÅ£¬£¬£¬£¬£¬£¬Òò´Ëµ¼ÖÂÁ˲î±ðµÄƽ¾ù¿ÅÁ£¾Þϸ£¬£¬£¬£¬£¬£¬ÏêϸÊý¾ÝÏê¼ûÏ·½Áбí¸ñ¡£¡£ÕâЩÏà¶Ô½ÏСµÄƽ¾ù¿ÅÁ£¾ÞϸÔÚÌáÉýÉúÎïʹÓöȷ½Ãæ¾ßÓÐÎüÒýÁ¦£¬£¬£¬£¬£¬£¬ÓÉÓÚÆ½¾ù¿ÅÁ£¾ÞϸÊÇÓ°ÏìÄÉÃ×ÖÆ¼ÁÉúÎïʹÓöȵÄÖ÷ÒªÒòËØÖ®Ò»¡£¡£ÔÚ½ºÌåµÝËÍϵͳÖУ¬£¬£¬£¬£¬£¬µ±¿ÅÁ£³ß´çËõСÖÁÄÉÃ×³ß´ç¹æÄ£Ê±£¬£¬£¬£¬£¬£¬·â×°µÄÇ×Ö¬»¯ºÏÎïµÄ¿Ú·þÉúÎïʹÓöÈÒ²»áÔöÌí¡£¡£

ºÀÃŹú¼Ê¡¤(Öйú¼¯ÍÅ)¹Ù·½ÍøÕ¾

²î±ðÍâò»îÐÔ¼ÁÐÞÊεÄÄÉÃ×CoQ10µÄÎïÀí»¯Ñ§ÐÔ×ÓÒÔ¼°ÄÉÃ×CoQ10ÔÚÃÜ·â×ØÉ«Æ¿ÖÐÖü´æ180Ììʱ´úÔÚ25¡æÌõ¼þϵÄÎȹÌÐÔ¡£¡£


      ÄÉÃ×CoQ10µÄÎïÀí״̬Ñо¿Õ¹ÏÖÁËÆäÓëͨË×CoQ10µÄ²î±ð£¬£¬£¬£¬£¬£¬ºóÕßÔÚ¼ÓÈÈʱ»á·ºÆðÌØÕ÷ÐÔµÄÎüÈȷ壬£¬£¬£¬£¬£¬¶øÄÉÃ×CoQ10ÔòûÓÐÕâÖÖÌåÏÖ¡£¡£Æä³¬Àä̬µÄ±£´æ¿ÉÄÜÊÇÄÉÃ׳ߴçЧӦËùÖ£¬£¬£¬£¬£¬£¬Õâһ״̬ÔÚÎïÀí»¯Ñ§ÉϾßÓÐÎȹÌÐÔµÄÓÅÊÆ£¬£¬£¬£¬£¬£¬¿É×èÖ¹½á¾§£¬£¬£¬£¬£¬£¬Ìṩ½Ï³¤Ê±¼äµÄ¼á³ÖÎȹÌÐÔ¡£¡£È»¶ø£¬£¬£¬£¬£¬£¬³¬Àä̬µÄ²»ÎȹÌÐÔÒ²ÐèÒª½øÒ»²½Ñо¿ÒÔ¸üÖÜÈ«µØÏàʶÆäÔÚÒ©Îï²úÆ·ÖеÄÊÊÓÃÐÔºÍÎȹÌÐÔ¡£¡£


ºÀÃŹú¼Ê¡¤(Öйú¼¯ÍÅ)¹Ù·½ÍøÕ¾

¸¨Ã¸Q10¡¢Íâò»îÐÔ¼ÁºÍÄÉÃ׸¨Ã¸Q10µÄDSC£¨²îʾɨÃèÁ¿ÈÈ·¨£©ÇúÏß


   Ö¬ÈÜÐÔ¸¨ÁÏÔÚÅäºÏ¿Ú·þµÄÖ¬ÈÜÐÔÒ©ÎïÎüÊÕ·½Ãæ¾ßÓÐÏÔÖøÓ°Ïì¡£¡£Íâò»îÐÔ¼Á¿ÉÒԸıäϸ°ûĤÍêÕûÐÔºÍϸÃÜÅþÁ¬£¬£¬£¬£¬£¬£¬Í¬Ê±ÒÖÖÆP-ÌÇÂѰ׵ÈÍâÅÅתÔËÌå¡£¡£ÕâЩÍâò»îÐÔ¼ÁÓÐÍû¼õÇá¿Ú·þÒ©ÎïÉúÎïʹÓöȵÄÏÞÖÆ£¬£¬£¬£¬£¬£¬ÓÈÆäÊÇͨ¹ýÒÖÖÆP-ÌÇÂѰ׵Ä×÷Óᣡ£ÔÚ¿Ú·þºó£¬£¬£¬£¬£¬£¬Ê¹ÓÃÍâò»îÐÔ¼Á¾ÙÐÐÐÞÊοÉÌá¸ß¸¨Ã¸Q10µÄAUC£¨Ò©ÎïÇúÏßϵÄÃæ»ý£©£¬£¬£¬£¬£¬£¬ÆäЧ¹ûÅÅÐòΪ£º

   PHCO¡ÖPSAE > SP ¡Ö TPGS > SL¡£¡£

ºÀÃŹú¼Ê¡¤(Öйú¼¯ÍÅ)¹Ù·½ÍøÕ¾

ÄÉÃ׸¨Ã¸Q10ºÍÍâò»îÐÔ¼Á¡¢¸¨Ã¸Q10µÄѪҩŨ¶È±ÈÕÕ


   Ñо¿Öн«¸¨Ã¸Q10ÖÆ±¸ÎªÎÞÖ¬ÖÊÄÉÃ׸¨Ã¸Q10ϵͳ£¬£¬£¬£¬£¬£¬ÒÔÌá¸ßÆäÏûÈڶȺͿڷþÉúÎïʹÓöÈ¡£¡£½ÓÄɲî±ðÍâò»îÐÔ¼Á¶ÔÄÉÃ׸¨Ã¸Q10¾ÙÐÐÐÞÊΣ¬£¬£¬£¬£¬£¬Ð§¹ûÏÔʾÎÞÖ¬ÖÊÄÉÃ׸¨Ã¸Q10ÔÚ¿Ú·þºóÏÔÖøÌá¸ßÁ˸¨Ã¸Q10µÄÉúÎïʹÓöÈ¡£¡£


   Ñо¿Åú×¢£¬£¬£¬£¬£¬£¬Íâò»îÐÔ¼ÁÔÚ¸ÄÉÆ¸¨Ã¸Q10ÉúÎïʹÓöȷ½ÃæÊ©Õ¹ÁËÖ÷Òª×÷Ó㬣¬£¬£¬£¬£¬ÐÞÊκóµÄÎÞÖ¬ÖÊÄÉÃ׸¨Ã¸Q10µÄÉúÎïʹÓöÈÉõÖÁÁè¼ÝÁË»ùÓÚÖ¬ÖʵÄÄÉÃ×ÈéÒº¡£¡£Òò´Ë£¬£¬£¬£¬£¬£¬ÎÞÖ¬ÖÊÄÉÃ׸¨Ã¸Q10ÖÆ¼ÁÔÚÌá¸ß¸¨Ã¸Q10¿Ú·þÉúÎïʹÓöȷ½Ãæ¾ßÓÐDZÔÚÓ¦ÓüÛÖµ£¬£¬£¬£¬£¬£¬Íâò»îÐÔ¼ÁÔÚÆäÖÐÊÎÑÝÒªº¦½ÇÉ«¡£¡£


Reference£º

[1] H. Zhou et al., ¡°Novel Lipid-Free Nanoformulation for Improving Oral Bioavailability of Coenzyme Q10,¡± Biomed Res. Int., vol. 2014, 2014.

[2] Tr. Kommuru, B. Gurley, M. A. Khan, and I. K. Reddy, ¡°Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment,¡± Int. J. Pharm., vol. 212, no. 2, pp. 233¨C246, 2001.

[3] K. Nukui, T. Yamagishi, H. Miyawaki, A. Kettawan, T. Okamoto, and K. Sato, ¡°Comparison of uptake between PureSorb-QTM 40 and regular hydrophobic coenzyme Q10 in rats and humans after single oral intake,¡± J. Nutr. Sci. Vitaminol. (Tokyo)., vol. 53, no. 2, pp. 187¨C190, 2007, doi: 10.3177/jnsv.53.187.

·ÖÏíµ½£º

ÔĶÁ¸ü¶àÎÄÕÂ
READ MORE

]]>
/?feed=rss2&p=40304 0
¿ÚÇ»ð¤Ä¤µÝËÍ£º×¿Ô½µÄÓªÑøËØÎüÊÕ;¾¶ /?p=40087 /?p=40087#comments Tue, 25 Mar 2025 06:53:24 +0000 http://www.jialanhai.com/?p=40087

ÉÅʳGABAµÄÉñÃØÊµÁ¦£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³×

2025-09-30 14:06

   ÓªÑøËصÝËÍͨµÀÊÇÖ¸½«ÓªÑøËØ£¨ÈçάÉúËØ¡¢¿óÎïÖÊ¡¢ÂѰ×Öʵȣ©´ÓÍâ½çÎüÊÕ²¢ÔËË͵½Ï¸°ûÄÚ£¬£¬£¬£¬£¬£¬ÒÔÖª×ãÉíÌåµÄÓªÑøÐèÇ󡣡£ÓªÑøËصÝËÍͨµÀ¿ÉÒÔ·ÖΪ¿Ú·þ¡¢¿ÚǻճĤ¡¢×¢ÉäµÈ£¬£¬£¬£¬£¬£¬Ã¿ÖÖ·½Ê½¶¼ÓÐÆäÌØ¶¨µÄÓÅÊÆºÍÊÊÓó¡¾°¡£¡£


   ÔÚ¿Ú·þ·½Ê½ÖУ¬£¬£¬£¬£¬£¬ÓªÑøËØ¿ÉÒÔͨ¹ý賦µÀ±»ÎüÊÕ£¬£¬£¬£¬£¬£¬È»ºó½øÈëѪҺѭ»·£¬£¬£¬£¬£¬£¬±»ÔËË͵½ÉíÌå¸÷¸ö²¿Î»¡£¡£¶ø¿ÚÇ»ð¤Ä¤ÎüÊÕͨµÀÊÇÒ»ÖÖͨ¹ý¿ÚÇ»ð¤Ä¤Ñ¸ËÙÎüÊÕÓªÑøËØµÄ·½Ê½£¬£¬£¬£¬£¬£¬×èÖ¹ÁËθËáµÈÒòËØµÄÓ°Ï죬£¬£¬£¬£¬£¬´Ó¶øÊµÏÖ¸ü¿ìµÄЧ¹û¡£¡£


   ×¢ÉäÊÇÁíÒ»ÖÖÓªÑøËØµÝËÍͨµÀ£¬£¬£¬£¬£¬£¬Í¨¹ý½«ÓªÑøËØÖ±½Ó×¢ÈëÌåÄÚ£¬£¬£¬£¬£¬£¬¿ÉÒÔÈÆ¹ý賦µÀµÄÎüÊÕÀú³Ì£¬£¬£¬£¬£¬£¬Ö±½Ó½øÈëѪҺѭ»·£¬£¬£¬£¬£¬£¬¾ßÓиü¸ßµÄÉúÎïʹÓÃÂÊ¡£¡£ÕâÖÖ·½Ê½³£ÓÃÓÚÐèҪѸËÙÔö²¹´ó×ÚÓªÑøËØµÄÇéÐΡ£¡£


   ×ÜÖ®£¬£¬£¬£¬£¬£¬ÓªÑøËصÝËÍͨµÀÊǽ«ÓªÑøÎïÖÊ´ÓÍâ½çת´ïµ½ÌåÄÚϸ°ûµÄ;¾¶£¬£¬£¬£¬£¬£¬²î±ðµÄͨµÀ·½Ê½ÊÊÓÃÓÚ²î±ðµÄÇéÐκÍÐèÇ󡣡£


×÷Éõ¿ÚǻճĤµÝËÍͨµÀ


   ¿ÚÇ»ð¤Ä¤µÝËÍͨµÀÊÇÒ»ÖÖÁ¢ÒìµÄÒªÁ죬£¬£¬£¬£¬£¬ÓÃÓÚ½«ÓªÑøËØºÍÆäËûÉúÎï»îÐÔÎïÖÊת´ïµ½ÈËÌåÄÚ£¬£¬£¬£¬£¬£¬Í¨¹ý¿ÚÇ»ð¤Ä¤µÄÎüÊÕÀ´ÊµÏÖ¿ìËÙ¶øÓÐÓõÄÎüÊÕºÍת´ï¡£¡£Õâһת´ï;¾¶Ö÷Òª·ÖΪÁ½ÖÖ·½Ê½£ºÉàϵÝËͺͼÕĤµÝËÍ¡£¡£


   ÉàϵÝËÍÊǽ«ÓªÑøËØ»òÉúÎï»îÐÔÎïÖÊÖ±½Ó·ÅÖÃÔÚÉàÏÂð¤Ä¤Ï£¬£¬£¬£¬£¬£¬Ê¹Æäͨ¹ýð¤Ä¤½øÈëѪҺѭ»·¡£¡£ÉàÏÂð¤Ä¤¸»ºñµÄѪ¹ÜÍøÂçºÍëϸѪ¹Ü¿ÉÒÔÔö½øÎïÖʵĿìËÙÎüÊÕ£¬£¬£¬£¬£¬£¬Èƹý賦µÀµÄÏû»¯ºÍ´úл£¬£¬£¬£¬£¬£¬´Ó¶øÊµÏÖ¸ü¸ßµÄÉúÎïʹÓÃÂʺ͸ü¿ìµÄЧ¹û¡£¡£


   ¼ÕĤµÝËÍÊǽ«ÎïÖÊ·ÅÖÃÔÚ¼Õ²¿ÄÚ²àð¤Ä¤ÉÏ£¬£¬£¬£¬£¬£¬Í¨¹ý¼Õð¤Ä¤µÄÎüÊÕ½øÈëÑ­»·ÏµÍ³¡£¡£ÕâÖÖ·½Ê½Ò²Äܹ»×èÖ¹ÎïÖÊÔÚ賦µÀÖеĽµ½âºÍ´úл£¬£¬£¬£¬£¬£¬Ìá¸ßÆäÉúÎïʹÓÃÂÊ¡£¡£


   ÕâЩ¿ÚÇ»ð¤Ä¤µÝËÍͨµÀÔÚÓªÑøÔö²¹ºÍ±£½¡·½Ãæ¾ßÓÐDZÔÚÓ¦Óᣡ£Í¨¹ýÕâЩ;¾¶£¬£¬£¬£¬£¬£¬ÈËÃÇ¿ÉÒÔ¸üÓÐÓõػñÈ¡ËùÐèµÄÓªÑøËØºÍÉúÎï»îÐÔÒòËØ£¬£¬£¬£¬£¬£¬´Ó¶øÊµÏÖ¸üºÃµÄ¿µ½¡ºÍÉúÑÄÖÊÁ¿¡£¡£È»¶ø£¬£¬£¬£¬£¬£¬Ñ¡ÔñºÏÊʵĵÝËÍ·½Ê½ÐèҪ˼Á¿ÎïÖʵÄÌØÕ÷¡¢Ä¿µÄЧ¹ûºÍ¸öÌå²î±ð¡£¡£Ëæ×ÅÑо¿µÄÒ»Ö±ÉîÈ룬£¬£¬£¬£¬£¬¿ÚÇ»ð¤Ä¤µÝËÍͨµÀÓÐÍûÔÚÓªÑøÔö²¹ÁìÓòʩչԽÀ´Ô½Ö÷ÒªµÄ×÷Óᣡ£


ÉàÏÂð¤Ä¤ºÍ¼Õð¤Ä¤Ö®¼äµÄÉøÍ¸²î±ð


   ÉàÏÂð¤Ä¤ºÍ¼ÕĤ֮¼äµÄÆÊ½âºÍÉøÍ¸ÐÔ²î±ðÐèÒª²î±ðµÄµÝËÍͨµÀÉè¼Æ¡£¡£ÓÉÓÚÉàÏÂð¤Ä¤¾ßÓиßÉøÍ¸ÐԺ͸»ºñµÄѪҺ¹©Ó¦£¬£¬£¬£¬£¬£¬Òò´ËËüÄܹ»¿ìËÙÎüÊÕ£¬£¬£¬£¬£¬£¬Ñ¸ËÙ±¬·¢×÷Ó㬣¬£¬£¬£¬£¬²¢¾ßÓнϸߵÄÉúÎïʹÓÃÂÊ¡£¡£ÉàÏÂð¤Ä¤×îÊʺÏʹÓÃС¿ÅÁ£µÄµÝËÍͨµÀ£¬£¬£¬£¬£¬£¬ÔÚ¶Ìʱ¼äÄÚÒÔ¸ßŨ¶ÈÌṩ»¯ºÏÎï¡£¡£ÄÉÃ×¼¶£¨½éÓÚ20µ½200ÒÚ·ÖÖ®Ò»Ã×Ö®¼ä£©µÄ¹ÌÌåÖ¬ÖʺÍÒºµÎÖ¬ÖÊÄÉÃ×Çò¾ßÓÐÀíÏëµÄ×é³ÉºÍ·Ö×ӽṹ£¬£¬£¬£¬£¬£¬ÊÊÓÃÓÚÉàϵÝËÍͨµÀ¡£¡£


   ¼ÕĤµÄÉøÍ¸ÐÔÏÔ×ŵÍÓÚÉàÏÂÇøÓò£¬£¬£¬£¬£¬£¬²»¾ß±¸ÉàϵÝË͵ĿìËÙÎüÊÕºÍÓÅÔ½ÉúÎïʹÓÃÂÊ¡£¡£ÔÚ¶àÏî½ÏÁ¿Ñо¿ÖУ¬£¬£¬£¬£¬£¬ÉàϵÝËÍЧ¹û±È¼ÕĤµÝË͸üΪÓÐÓᣡ£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDMvM2QwODg5ZjRhYzkyOTFhODU4ZGM0Y2VhYjIzN2MwNDUucG5n


×÷ÉõÄÉÃ×Çò


   Í¨¹ý¿ÚÇ»ð¤Ä¤µÝËÍÓªÑøÔö²¹¼ÁºÍ±£½¡Æ·µÄ½â¾ö·½°¸ÔÚÓÚ½«ÉúÎﻯºÏÎï·â×°µ½¸ßÉøÍ¸ÐÔµÄÖ¬ÖÊÄÉÃ×ÇòÖС£¡£ÕâЩÄÉÃ×Çò¿ÉÒÔͨ¹ýµÎ¹ÜÇáËɵØÍ¶·Åµ½¿ÚÇ»µÄÉàÏÂð¤Ä¤£¬£¬£¬£¬£¬£¬ÒÔ±ã¿ìËÙ±»ÎüÊÕ½øÈëÑ­»·ÏµÍ³¡£¡£


1.ÄÉÃ×ÇòµÄ»ù´¡£¡£ºÄÉÃ×ÇòÊÇÓÉÇå¾²µÄÁ×Ö¬¡¢Ö¬·¾ËáºÍÍâò»îÐÔ¼Á×é³ÉµÄ£¬£¬£¬£¬£¬£¬¾ßÓиßÉøÍ¸ÐԺͱ£»£»£»£»£»£»¤ÐÔ¡£¡£Æä½¹µã×é³ÉÎïÖÊÁ×Ö¬õ£µ¨¼î·ÖÊý´¿¶ÈÁè¼Ý60%£¬£¬£¬£¬£¬£¬¿É¶¯Ì¬µØ±£»£»£»£»£»£»¤Ëù·â×°µÄÉúÎï»îÐÔÎïÖÊ¡£¡£ÕâЩÄÉÃ×ÇòÓëÉúÎïĤºÍÖ¬ÂѰ׵ÄÖ÷ÒªÒòËØÏàͬ£¬£¬£¬£¬£¬£¬¶Ôϸ°ûĤ¸ß¶ÈÉøÍ¸£¬£¬£¬£¬£¬£¬Äܹ»ÓÐÓõطâ×°ÖÖÖÖÉúÎï»îÐÔÎïÖÊ£¬£¬£¬£¬£¬£¬ÊµÏÖ¿ìËٵĿÚÇ»ð¤Ä¤×ª´ï¡£¡£


2.ÑÇ΢Ã×ÒþÐÎÇòÌ壺ÄÉÃ×ÇòµÄ³ß´ç¶ÔÆäЧ¹ûÖÁ¹ØÖ÷Òª£¬£¬£¬£¬£¬£¬Ö±¾¶ÔÚ20ÄÉÃ×µ½200ÄÉÃ×Ö®¼äµÄÄÉÃ×ÇòÑ­»·Ê±¼ä½Ï³¤¡£¡£¸üСµÄÄÉÃ×Çò¾ßÓÐÒþÉíÌØÕ÷£¬£¬£¬£¬£¬£¬¿ÉÒÔ×èÖ¹ÃâÒßϵͳ¼ì²â²¢ÌṩÒþ²ØÔØÌå¡£¡£ËüÃǵÄÄÉÃ׳ߴçʹÆäÄܹ»´©Ô½Ï¸°ûºÍĤÆÁÕÏ£¬£¬£¬£¬£¬£¬ÉõÖÁ´©Ô½ÑªÄÔÆÁÕϽø×ÅÃÔ¾­ÏµÍ³ÇøÓò¡£¡£ÄÉÃ×Çòת´ïϵͳ¾ßÓпìËÙÎüÊÕ¡¢Ìá¸ßÉúÎïʹÓöȡ¢¿ìËÙʩչ×÷Óá¢Î¬³Ö¸ßѪ½¬Ë®Æ½ÒÔ¼°¸ÄÉÆÉúÎïЧӦµÈÓŵã¡£¡£


aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDMvNzllNTE4OGU0ZTkxNTY2ZWZhMWZlMTFkZGMzY2ZhNDkucG5n


   ÄÉÃ×ÇòÒѱ»Ö¤Êµ¾ßÓÐÒÔÏÂÓÅÊÆ£º

1.ͨ¹ý¾­ð¤Ä¤ÎüÊÕµÝËÍÀ´ÔöÌíÉúÎïʹÓöÈ

2.¸ü³¤ÆÚµÄѪҺˮƽ£¬£¬£¬£¬£¬£¬¸ü¸ßµÄÉúÎïЧӦºÍ³ÖÐøÊ±¼ä¸ü³¤µÄÒæ´¦

3.¸ü¸ßЧµÄ·´Ó³£¬£¬£¬£¬£¬£¬ÔÊÐíïÔÌ­ÓÃÁ¿ºÍʹÓÃÆµÂÊ

4.½«±»×è¸ôµÄ»¯ºÏÎïÔËÊä´©¹ýѪÄÔÆÁÕϲ¢½øÈëÄԽṹ

5.¸ÄÉÆÓû§±ãµ±ÐÔ£¨ïÔ̭ʹÓÃÆµÂʺ͸üÈÝÒ××ñ´Ó£©

6.ÑÓÉìµÄÑ­»·°ëË¥ÆÚ£¨ÓëÒ©ÎïµÝË͸ººÉµÄÑо¿ÒѾ­Ö¤Êµ¿ÉÔöÌí100±¶£¬£¬£¬£¬£¬£¬´Ó¶øÏÔÖøÌá¸ßЧÁ¦-×î¸ß¿É´ï500±¶£©


Reference£º

1.Shojaei, A. H., Chang, R. K., Guo, X., Burnside, B. A., & Couch, R. A. (2001). Systemic drug delivery via the buccal mucosal route. Pharmaceutical technology25(6), 70-81.

2.Harris, D., & Robinson, J. R. (1992). Drug delivery via the mucous membranes of the oral cavity. Journal of pharmaceutical sciences81(1), 1-10.

3.Washington, N., Washington, C., & Wilson, C. (2000). Physiological pharmaceutics: barriers to drug absorption. CRC Press.

4.Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. J Control Release 2011 Jul 30;153(2):106-16.

5.Shojaei, A. H. (1998). Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharm Sci, 1(1), 15-30.

6.Hua, S. (2019). Advances in nanoparticulate drug delivery approaches for sublingual and buccal administration. Frontiers in pharmacology10, 1328.

7.Reza Mozafari, M., Johnson, C., Hatziantoniou, S., & Demetzos, C. (2008). Nanoliposomes and their applications in food nanotechnology. Journal of liposome research, 18(4), 309-327.

·ÖÏíµ½£º

ÔĶÁ¸ü¶àÎÄÕÂ
READ MORE

]]>
/?feed=rss2&p=40304 0
¶ÌÏÞÆÚÏõËáÑκ͹ϰ±ËáÁªºÏÔö²¹¶Ô¾«Ó¢ÈüͧÔË·¢¶¯Ô˶¯ÌåÏÖµÄÓ°Ïì /?p=40031 /?p=40031#comments Thu, 13 Mar 2025 06:06:01 +0000 http://www.jialanhai.com/?p=40031

ÉÅʳGABAµÄÉñÃØÊµÁ¦£º½âËøÉñ¾­ÏµÍ³¿µ½¡µÄÔ¿³×

2025-09-30 14:06
   ÔÚÔ˶¯¿ÆÑ§ÁìÓò£¬£¬£¬£¬£¬£¬Ì½Ñ°ÌáÉýÔË·¢¶¯ÌåÏÖµÄÓÐÓÃÒªÁìʼÖÕÊÇÈÈÃÅÑо¿Æ«Ïò¡£¡£½üÆÚÒ»ÏîÕë¶Ô¾«Ó¢ÈüͧÔË·¢¶¯µÄÑо¿¾Û½¹ÓÚ¶ÌÏÞÆÚ£¨1ÖÜ£©¿Ú·þÁªºÏÔö²¹3.5¿ËÌð²Ë¸ùÌáÈ¡Îº¬500ºÁ¿ËÏõËáÑΣ©Óë6¿Ë¹Ï°±ËáËù±¬·¢µÄЧ¹û¡£¡£¸ÃÑо¿½«ÆäÓëο½å¼ÁºÍµ¥¶ÀµÄÌð²Ë¸ùÔö²¹¼Á±ÈÕÕ£¬£¬£¬£¬£¬£¬ÉîÈë̽ÌÖ¶Ô¾«Ó¢ÄÐÐÔÈüͧÔË·¢¶¯ÓÐÑõÄÜÁ¦¡¢×ʵÁ¦ÒÔ¼°¸ßÇ¿¶È¹¦ÂʺͷåÖµ»®½°µÈ·½ÃæµÄÓ°Ïì¡£¡£Ñо¿Ð§¹ûÏÔʾ£¬£¬£¬£¬£¬£¬ÕâÖÖÁªºÏÔö²¹ÔÚÒ»¶¨Ë®Æ½ÉϸÄÉÆÁËWingate²âÊÔºóµÄÈéËáɨ³ýÂʺÍÐÔÄܲâÊÔÖеķåÖµ¹¦ÂÊ£¬£¬£¬£¬£¬£¬²»¹ýÔÚÆäËûÈç×î´óÉãÑõÁ¿£¨VO?peak£©ºÍ×î´óÐÄÂʵÈÏà¹ØÐÄÀí²ÎÊýÉÏ£¬£¬£¬£¬£¬£¬²¢Î´·ºÆð³öÏÔ×Ųî±ð1¡£¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDMvOGYxMWQxYmE2YTk4Njk5NWNkN2QzNWYyNDkzMWIxODgucG5n


1.ÏõËáÑκ͹ϰ±ËáµÄ½éÉÜ
 
 1.1 ÏõËáÑÎ

   ÏõËáÑÎÊÇÒ»Ñõ»¯µª£¨NO£©µÄÖ÷ҪǰÌåÎïÖÊ¡£¡£ÔÚÈËÌåÐÄÀíÀú³ÌÖУ¬£¬£¬£¬£¬£¬NO ¾ßÓм«ÎªÒªº¦µÄ×÷Ó㬣¬£¬£¬£¬£¬ËüÓëÔ˶¯ÌåÏֵĶà¸ö·½ÃæÏ¸ÃÜÏàÁ¬£¬£¬£¬£¬£¬£¬ÀýÈç¶Ô×î´óÉãÑõÁ¿£¨VO?max£©¡¢Ô˶¯¾­¼ÃÐÔÒÔ¼° VO?max µÄ·ÖÊýʹÓÃÂʵÈÖ¸±êÓÐ×ÅÖ÷ÒªÓ°Ïì¡£¡£Ðí¶àÑо¿Î§ÈÆÏõËáÑÎÔö²¹¼ÁÕö¿ª£¬£¬£¬£¬£¬£¬Ïñ³£¼ûµÄ¸»º¬ÏõËáÑεÄÌð²Ë¸ù£¨BR£©ÌáÈ¡Î£¬£¬£¬£¬£¬ÆäÔö²¹ºóÄܹ»ÌáÉýÑ­»·ÏõËáÑΣ¨NO??£©Ë®Æ½£¬£¬£¬£¬£¬£¬½ø¶øÔö½ø NO µÄÌìÉú¡£¡£NO µÄ±¬·¢ÓÐÖúÓÚѪ¹ÜÊæÕÅ£¬£¬£¬£¬£¬£¬ÔöÌíѪҺÁ÷Ïò¼¡Èâ×éÖ¯£¬£¬£¬£¬£¬£¬´Ó¶ø¸ÄÉÆÑõÆø¹©Ó¦£¬£¬£¬£¬£¬£¬ÎªÔ˶¯Öеļ¡ÈâÌṩ¸ü¸»×ãµÄÄÜÁ¿Ö§³Ö£¬£¬£¬£¬£¬£¬ÔÚÔ˶¯Àú³ÌÖÐʩչ×ÅÖ÷ÒªµÄÐÄÀíµ÷Àí¹¦Ð§¡£¡£

 1.2 ¹Ï°±Ëá

   ¹Ï°±ËᣨCIT£©×÷ΪһÖÖ°±»ùËᣬ£¬£¬£¬£¬£¬¾ßÓÐDZÔÚµÄÔöÇ¿Ô˶¯ÄÜÁ¦µÄÌØÕ÷¡£¡£ËüÔÚÈËÌå´úлÖмÓÈëÖ÷ÒªµÄÐÄÀíÀú³Ì£¬£¬£¬£¬£¬£¬ÌØÊâÊÇÔÚÔ˶¯Àú³ÌÖУ¬£¬£¬£¬£¬£¬±»ÒÔΪ¿ÉÒÔïÔÌ­¸ßÇ¿¶ÈÔ˶¯Ê±´úѪҺÈéËáµÄ»ýÀÛºÍËáÖж¾µÄ±¬·¢¡£¡£µ±ÑªÒºÖÐÈéËá»ýÀÛïÔ̭ʱ£¬£¬£¬£¬£¬£¬Äܹ»¼õÇἡÈâÆ£ÀÍ£¬£¬£¬£¬£¬£¬Ê¹¼¡ÈâÔÚÔ˶¯Öмá³Ö¸üºÃµÄÊÂÇé״̬£¬£¬£¬£¬£¬£¬½ø¶ø¿ÉÄÜÌá¸ßÓÐÑõÄÜÁ¦ºÍ¼¡ÈâʵÁ¦µÄ±¬·¢¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬CIT»¹¾ßÓд̼¤¼¡ÈâÂѰ×ÖʺϳɵÄ×÷Ó㬣¬£¬£¬£¬£¬Õâ¹ØÓÚά³ÖºÍÔöÇ¿¼¡ÈâÖÊÁ¿¡¢ÌáÉý¼¡ÈâʵÁ¦¾ßÓÐÖ÷ÒªÒâÒ壬£¬£¬£¬£¬£¬ÔÚÔ˶¯ÓªÑøÁìÓòÊܵ½ÁËÆÕ±é¹Ø×¢¡£¡£


2.ÏõËáÑκ͹ϰ±Ëá¶ÔÔË·¢¶¯µÄÓ°Ïì
 
 2.1µ¥¶ÀÔö²¹µÄЧ¹û

   ÒÔÍùµÄÑо¿Åú×¢£¬£¬£¬£¬£¬£¬µ¥¶ÀÔö²¹BR¶ÔÔË·¢¶¯µÄÔ˶¯ÌåÏÖÓÐÒ»¶¨µÄÆð¾¢Ó°Ïì¡£¡£ÀýÈ磬£¬£¬£¬£¬£¬ÔÚһЩÄÍÁ¦ÏîÄ¿ÖУ¬£¬£¬£¬£¬£¬ÔË·¢¶¯ÔÚÔ˶¯Ç°ÉãÈëBR£¬£¬£¬£¬£¬£¬Äܹ»Ëõ¶ÌÍê³ÉÌØ¶¨¾àÀëµÄʱ¼ä£¬£¬£¬£¬£¬£¬ÈçÔÚ×ÔÐгµÏîÄ¿ÖÐïÔÌ­Íê³É4km¼ÆÊ±ÈüµÄ×Üʱ¼ä£¬£¬£¬£¬£¬£¬ÔÚÈüͧÏîÄ¿ÖÐÒ²ÓÐÀàËÆµÄÌáÉýÔ˶¯ÌåÏÖµÄÇéÐΡ£¡£ÕâÖ÷Òª¹éÒòÓÚBR¶ÔѪ¹Ü¹¦Ð§µÄ¸ÄÉÆ£¬£¬£¬£¬£¬£¬ÔöÌíÁËѪҺ¹©Ó¦ºÍ×éÖ¯ÑõºÏ£¬£¬£¬£¬£¬£¬Ê¹µÃ¼¡ÈâÔÚÔ˶¯Àú³ÌÖÐÄܹ»»ñµÃ¸ü¸»×ãµÄÑõÆøºÍÓªÑøÎïÖÊ£¬£¬£¬£¬£¬£¬´Ó¶øÌá¸ßÔ˶¯Ð§ÂÊ¡£¡£
   CITµ¥¶ÀÔö²¹Ê±£¬£¬£¬£¬£¬£¬ÔÚһЩÑо¿ÖÐÒ²ÏÔʾ³ö¶ÔÔ˶¯ÌåÏÖµÄÔö½ø×÷Óᣡ£ÔÚÌØ¶¨µÄÔ˶¯²âÊÔÖУ¬£¬£¬£¬£¬£¬ÈçÔÚѵÁ·ÓÐËØµÄÄÐÐÔÖУ¬£¬£¬£¬£¬£¬Ô˶¯Ç°1СʱÉãÈëCIT¿ÉïÔÌ­Íê³É4kmËùÐèµÄʱ¼ä£»£»£»£»£»£»ÔÚ¿µ½¡ÄÐÐÔºÍÅ®ÐÔÖУ¬£¬£¬£¬£¬£¬Ô˶¯Ç°3СʱÉãÈëCITÄܹ»ÑÓÉìÔ˶¯ÖÁÁ¦½ßµÄʱ¼ä¡£¡£ÕâÅú×¢CITÔÚÌá¸ßÓÐÑõÄÜÁ¦ºÍÄÍÁ¦·½Ãæ¾ßÓÐÒ»¶¨µÄDZÁ¦£¬£¬£¬£¬£¬£¬Æä»úÖÆ¿ÉÄÜÓëïÔÌ­ÈéËá»ýÀÛ¡¢¸ÄÉÆÄÜÁ¿´úлÒÔ¼°´Ì¼¤¼¡ÈâÂѰ×ÖʺϳɵÈÒòËØÓйØ¡£¡£


 2.2ÁªºÏÔö²¹µÄDZÔÚÓÅÊÆ

   Ëæ×ÅÑо¿µÄÉîÈ룬£¬£¬£¬£¬£¬ÏõËáÑκ͹ϰ±ËáÁªºÏÔö²¹µÄЧ¹ûÖð½¥Êܵ½¹Ø×¢¡£¡£´ÓÀíÂÛÉϽ²£¬£¬£¬£¬£¬£¬Á½Õß¶¼ÄÜÔö½øNOµÄ±¬·¢£¬£¬£¬£¬£¬£¬¿ÉÄܱ£´æÐ­Í¬×÷Óᣡ£ÔÚһЩÑо¿ÖÐÒѾ­·¢Ã÷ÁËÕâÖÖÁªºÏÔö²¹µÄÆð¾¢Ð§¹û¡£¡£ÀýÈ磬£¬£¬£¬£¬£¬ÔÚ¾­ÓÉѵÁ·µÄÌúÈËÈýÏîÔË·¢¶¯ÖУ¬£¬£¬£¬£¬£¬¾ÙÐÐ9ÖܵÄÁªºÏÔö²¹ºó£¬£¬£¬£¬£¬£¬ÓÐÑõÄÜÁ¦ºÍ×î´ó¼°ÄÍʵÁ¦Á¦¶¼ÓÐËùÌá¸ß£¬£¬£¬£¬£¬£¬Í¬Ê±ÔÚÉú»¯²ÎÊý·½ÃæÒ²ÏÔʾ³ö¸üºÃµÄ»Ö¸´×´Ì¬¡£¡£Õâ˵Ã÷ÁªºÏÔö²¹¿ÉÄÜͨ¹ý¶àÖÖÐÄÀí;¾¶ÅäÏàÖúÓ㬣¬£¬£¬£¬£¬¶ÔÔË·¢¶¯µÄÔ˶¯ÌåÏÖºÍÉíÌå»Ö¸´±¬·¢¸üÏÔÖøµÄÓ°Ï죬£¬£¬£¬£¬£¬ÎªÔË·¢¶¯µÄѵÁ·ºÍ½ÇÖðÌṩ¸üÓÐÁ¦µÄÖ§³Ö¡£¡£

aHR0cHM6Ly93d3cuamlhbGFuaGFpLmNvbS9xZnktY29udGVudC91cGxvYWRzLzIwMjUvMDMvMjQ5ZWZjMDNiMDEzMzI1ZTQwODFlYTExMzdjYmMxZGYucG5n

3.Õ¹Íû

   ËäÈ»±¾´ÎÑо¿ÔÚ¶ÌÏÞÆÚÁªºÏÔö²¹·½ÃæÈ¡µÃÁËÒ»¶¨µÄЧ¹û£¬£¬£¬£¬£¬£¬µ«ÈÔ±£´æÒ»Ð©¾ÖÏÞÐÔ¡£¡£ÀýÈ磬£¬£¬£¬£¬£¬Ñо¿ÖÐδÉèÖýöÔö²¹CITµÄ±ÈÕÕ×飬£¬£¬£¬£¬£¬ÕâʹµÃÄÑÒÔÖ±½Ó½ÏÁ¿CITµ¥¶À×÷ÓÃÓëÁªºÏÔö²¹µÄЧ¹û²î±ð¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬Ñо¿½öͨ¹ýѪҺָ±êºÍÔ˶¯ÌåÏÖ²âÊÔ¾ÙÐÐÆÀ¹À£¬£¬£¬£¬£¬£¬È±·¦¶Ô¼¡Èâ×éÖ¯µÄÖ±½ÓÆÊÎö£¬£¬£¬£¬£¬£¬È缡Èâ»î¼ìµÈ£¬£¬£¬£¬£¬£¬ÕâÏÞÖÆÁË¶ÔÆä×÷ÓûúÖÆµÄÉîÈëÏàʶ¡£¡£Í¬Ê±£¬£¬£¬£¬£¬£¬Î´Ë¼Á¿¸öÌ峦µÀ΢ÉúÎïȺ¶ÔÏõËáÑκ͹ϰ±Ëá´úлµÄÓ°Ï죬£¬£¬£¬£¬£¬¶øÕâ¿ÉÄÜÔÚÔö²¹¼ÁµÄЧ¹ûÖÐÆðµ½Ö÷Òª×÷Óᣡ£

   Î´À´µÄÑо¿¿ÉÒÔÕë¶ÔÕâЩȱ·¦Õö¿ª¡£¡£Ê×ÏÈ£¬£¬£¬£¬£¬£¬Ó¦Éè¼Æ¸üÖÜÈ«µÄʵÑé·½°¸£¬£¬£¬£¬£¬£¬°üÀ¨²î±ð¼ÁÁ¿¡¢²î±ðÔö²¹Ê±¼äÒÔ¼°²î±ðÔ˶¯ÏîÄ¿µÄÑо¿£¬£¬£¬£¬£¬£¬ÒÔÈ·¶¨×î¼ÑµÄÔö²¹Õ½ÂÔ¡£¡£Æä´Î£¬£¬£¬£¬£¬£¬ÉîÈë̽ÌÖÁªºÏÔö²¹µÄ×÷ÓûúÖÆ£¬£¬£¬£¬£¬£¬Í¨¹ý¶Ô¼¡Èâ´úл¡¢Éñ¾­¼¡È⹦ЧÒÔ¼°ÐÄѪ¹ÜϵͳµÄ×ÛºÏÑо¿£¬£¬£¬£¬£¬£¬ÖÜÈ«ÏàʶÆä¶ÔÔ˶¯ÌåÏÖµÄÓ°Ïì¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬»¹Ó¦¹Ø×¢²î±ðÐÔ±ð¡¢ÄêËêºÍÑ·üç®Æ½µÄÔË·¢¶¯´ºÁªºÏÔö²¹µÄ·´Ó³²î±ð£¬£¬£¬£¬£¬£¬Îª¸öÐÔ»¯µÄÓªÑøÔö²¹Ìṩ¿ÆÑ§ÒÀ¾Ý¡£¡£×ÜÖ®£¬£¬£¬£¬£¬£¬ÏõËáÑκ͹ϰ±ËáÁªºÏÔö²¹ÔÚÔË·¢¶¯Ô˶¯ÌåÏÖÌáÉý·½Ãæ¾ßÓÐÁÉÀ«µÄÑо¿Ô¶¾°£¬£¬£¬£¬£¬£¬Î´À´µÄÑо¿ÓÐÍûΪÔË·¢¶¯µÄѵÁ·ºÍÓªÑøÖ§³ÖÌṩ¸ü¾«×¼¡¢ÓÐÓõÄÖ¸µ¼¡£¡£

²Î¿¼ÎÄÏ×:

1.Viribay A, Alcantara JMA, L¨®pez I, Mielgo-Ayuso J, Casta?eda-Babarro A. Impact of a short-term nitrate and citrulline co-supplementation on sport performance in elite rowers: a randomized, double-blind, placebo-controlled crossover trial. Eur J Appl Physiol. 2024;124(6):1911-1923. doi:10.1007/s00421-024-05415-4

·ÖÏíµ½£º

ÔĶÁ¸ü¶àÎÄÕÂ
READ MORE

]]>
/?feed=rss2&p=40304 0